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Abstract  
In recent years stem cells and progenitor cells have been identified in the heart, 
changing the paradigm that the heart is a post mitotic organ. The paradigm shift that is 
emerging from these studies can change the understanding and therapeutic approach 
of heart diseases, opening new avenues in the field of cell therapy. Several genes have 
been identified as regulators of stem cell function and cardiomyocyte differentiation. 
More recently, microRNAs have been identified as master switches controlling 
proliferation and differentiation events and, in particular, to function as key regulators of 
cardiac development and response to stress. In this study, we proposed to identify 
novel regulators of stemness and differentiation of the stem cell population present in 
the adult heart, which may be used to manipulate cell fate in vivo. For this purpose we 
have used the mouse as a model organism to characterize microRNA and gene 
expression patterns from samples Sca1 positive heart stem cells, as well as samples 
from different populations including bone marrow (lineage negative) cells and 
embryonic heart cells (Embryonic Day 9) were determined. 
We were able to improve the initial methodologies of the study, establishing a 
microRNA profile from each cell population. Within the miR panel that was studied, a 
subset with relative high expression levels in heart stem cells was identified, which may 
act as negative regulators of differentiation and proliferation. Although the overall 
expression profile of Sca-1 positive cells is closer to bone marrow cells, the most highly 
expressed miRs in heart stem cells are distinctive and predicted to target key genes 
involved in the control of cell proliferation and adhesion, vascular function and 
cardiomyocyte differentiation.  
In the future, identified microRNAs will be subject of several functional studies, using 
modified oligonucleotides “antagomirs” to establish their role in the heart stem cell 
proliferation and differentiation. 
The results from this study offer new insights into the gene expression networks of 
these different cell populations and supporting the importance of this rising area in the 
field of cardiac development and disease. 
 
Key Words: MicroRNAs, heart, stem cells, cardiac disease, cardiac development 
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Resumo 
Recentemente as células estaminais foram identificadas no coração sugerindo que 
este órgão não é pós-mitótico. Estas novas descobertas podem mudar o 
conhecimento e as abordagens terapêuticas para a patologia cardíaca, revelando 
novas perspectivas no campo da terapia celular. A origem destas células estaminais 
cardíacas está ainda por esclarecer e pouco se conhece acerca da expressão genica 
que regula a sua proliferação, diferenciação e renovação. Foi já estabelecido que as 
funções das células estaminais e a diferenciação de cardiomiócitos são reguladas por 
diferentes genes e em particular por microRNAs (miRs) têm surgido como os principais 
reguladores do destino celular e desenvolvimento, facilitando assim a identificação de 
fenótipos celulares específicos (Wang et al,2008). 
O objectivo principal desta tese, foi identificar novos reguladores de estaminalidade e 
diferenciação da população de células estaminais presentes no coração adulto que 
podem ser usados com o propósito de manipular o destino celular in vivo.  
As células estaminais embrionárias e as células estaminais adultas regulam a 
formação de tecidos e homeostasia do organismo, derivando do blastocisto e dando 
origem ao feto. Vários tipos de células são originados durante o processo tais como 
células progenitoras e células estaminais tecidulares que eventualmente darão origem 
a todas as células do organismo (Suh et al, 2004). Estas células são mantidas por um 
conjunto de factores de transcrição chave, que por sua vez são regulados pela 
expressão de microRNAs, tais como e Oct4, Sox2, Nanog, Klf-4,c-Myc, Tcf3 and 
Lin28. Existem evidências de diferentes miRNAs que são expressos em diferentes 
tipos/estadios celulares, que podem ser capazes de regular a diferenciação e auto 
regulação que são as principais características das células estaminais. 
Comparando os perfis de expressão de microRNAs das células da medula óssea com 
células estaminais cardíacas e coração embrionário esperamos conseguir perceber se 
estas células tiveram origem na medula óssea e migraram posteriormente para o 
coração ou se originaram no próprio coração formando nichos (Baerzi et al, 2007). Ao 
aceder a este tipo de informação esperamos não só perceber a proveniência destas 
células, mas também identificar os microRNAs responsáveis pela manutenção do 
estado celular assim como do seu destino. 
Para este estudo foram escolhidas populações e tecidos celulares: células estaminais 
cardíacas sca1 positivas, células da medula óssea de linhagem negativa e corações 
embrionários de ratinho (E=9). Estas populações foram já referenciadas como tendo a 
capacidade de se diferenciarem em células cardíacas e tendo uma actividade 
proliferativa muito elevada após estímulo como células de medula óssea e células 
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estaminais cardíacas. No caso do coração embrionário optou-se pelo nono dia 
embrionário, não só porque neste estádio de desenvolvimento existem evidências da 
regionalização do coração, mas também porque que as células se encontram com 
elevada taxa de proliferação, sem estarem no entanto completamente diferenciadas. 
Este estádio apresenta também vantagens em termos técnicos, uma vez que nesta 
fase é consideravelmente fácil conseguir destacar o coração do embrião. 
Em primeiro lugar, foi necessário melhorar as técnicas de isolamento das populações 
celulares que já tinham sido estabelecidas para cultura celular. Foram então 
escolhidas as metodologias de isolamento e quantificação mais adequadas. Para 
preservar a qualidade do RNA extraído das amostras foi usado miRvanaTM miRNA 
Isolation Kit, sorteando-se em seguida as células por FACS (Fluorescent Activated Cell 
Sorting), quantificando-se finalmente as amostras após análise no Agilent 2100 
bioanalyzer. 
Os microRNAs constituem marcadores ideais para caracterização molecular, uma vez 
que são menos susceptíveis a degradação e alterações quando comparados a 
amostras de mRNA (Doleshal et al, 2008). Diversas abordagens para a detecção e 
quantificação de microRNAs já estão a ser desenvolvidas, mas não podem ser 
realizadas em casos de quantidades reduzidas de RNA. Por esta razão, foram 
adoptadas metodologias de qRT-PCR para avaliar os níveis de expressão de 
microRNAs, tais como a utilização de sondas TaqMan microRNA (Applied 
BioSystems) e um “array” de microRNAs de células estaminais para qPCR (Systems 
Biosciences), sendo que ambos revelaram grande sensibilidade e robustez na 
detecção e quantificação de microRNAs em amostras de reduzida quantidade de RNA. 
Apesar das dificuldades, fomos capazes de melhorar significativamente as 
metodologias de isolamento celular e de RNA, e no final deste trabalho conseguimos 
obter amostras de células estaminais cardíacas Sca1 com sinais de amplificação em 
qPCR para o gene endógeno sno202, comparáveis às obtidas para 1ng de RNA em 
amostras de coração embrionário. Desta forma, fomos capazes de obter um perfil 
ainda que preliminar, de algumas amostras de células estaminais cardíacas. Apesar 
destes progressos, ainda estamos muito próximos do limite mínimo de detecção de 
Agilent Bioanalyser (500-5000pg/µl), e por isso ainda estamos longe de atingir os 
valores mínimos para realizar perfis de expressão em larga escala. 
A fim de estabelecer o perfil de microRNAs de cada população, usamos então um 
array especifico que incluía microRNAs com funções referenciadas na diferenciação 
de células estaminais, verificando que cada população possuía um perfil distinto de 
microRNAs. 
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Para obter novas informações acerca das origens da população de células estaminais 
cardíacas, realizamos uma análise comparativa entre esta população e as restantes 
populações alvo neste estudo: células da medula óssea de linhagem negativa e 
células do coração embrionário. Foi então detectado um conjunto de microRNAs de 
elevada expressão na população de células estaminais cardíacas: miR-126; miR-125a; 
miR-125b, miR-23b and miR-23a. Estes microRNAs estão aparentemente envolvidos 
em diferentes processos de interesse, tendo como alvos vários genes que regulam as 
funções das células estaminais cardíacas. 
Para tentar perceber quais as funções celulares que estes microRNAs podem estar a 
regular, realizamos duas abordagens complementares de análise funcional para os 
microRNAs identificados nas células estaminais cardíacas. 
Desta forma, usamos a base de dados TargetScanTM, para identificar os alvos 
previstos dos microRNAs seleccionados. Esta lista de alvos foi então analisada no 
programa GoElite (versão 1.2.) para identificar os processos celulares e as vias em 
que estes poderiam estar incluídos. Esta análise revelou-se frutífera, uma vez que os 
microRNAs com grande expressão nas células estaminais cardíacas, estão 
aparentemente envolvidos em processos de regulação de factores de transcrição, 
desenvolvimento de vasos sanguíneos, diferenciação de células estaminais e 
crescimento de órgãos, nomeadamente miR-125a and miR-126. 
Outra abordagem utilizada, consistiu na utilização da base de dados GeneGo 
(MetaCore TM) para a identificação de alvos e reguladores já validados 
experimentalmente, dos microRNAs seleccionados, relacionando-os com redes de 
interacção relevantes para o controlo da proliferação e diferenciação de células 
cardíacas. Verificou-se que vários alvos dos microRNAs seleccionados estão 
envolvidos em diferentes processos cruciais para a função das células estaminais 
cardíacas.  
Em paralelo, foi também realizada uma análise de enriquecimento que apontou na 
mesma direcção das restantes análises, mostrando que os alvos e reguladores dos 
miRs seleccionados participam em diversos processos como diferenciação celular. 
Estas duas abordagens, apesar de terem bases distintas, actuam como complemento, 
servindo o mesmo propósito de obter novas informações acerca do papel dos 
microRNAs que caracterizam esta população de células estaminais cardíacas.  
Este estudo comparativo entre as três populações, revelou que apesar do perfil geral 
de células estaminais cardíacas Sca1 positivas ser mais próximo das células da 
medula óssea que pode dar algumas pistas acerca da sua origem, estas células 
revelam um perfil de microRNAs distinto. Este perfil parece ser uma mistura entre as 
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duas populações de células da medula óssea e de coração embrionário, constituindo 
um perfil distinto de ambas as populações. 
Diversos microRNAs detectados na população de células de medula óssea e coração 
embrionário foram já referenciados em outros estudos. miR-133a foi detectado com 
elevada expressão em amostras de coração embrionário, vindo de encontro ao facto 
de estar altamente expresso no músculo cardíaco. Este microRNA está também 
associado à patologia cardíaca, uma vez que a sua reduzida expressão pode causar 
hipertrofia cardíaca (Ivey and Srivastava, 2010).  
Outra observação interessante consiste na presença de vários microRNAs, também 
em coração embrionário, que estão referenciados como constituintes do cluster mir 17-
92. Este cluster está referenciado como estando envolvido em processos de 
desenvolvimento em cancro humano, como linfomas e cancro do pulmão (Ventura et 
al, 2008). Aumenta os níveis da proteína proapoptótica Bim, inibindo o 
desenvolvimento de células B (Doeble et al, 2010). Foi também referenciado que 
corações deficientes neste cluster apresentam defeitos septais, indicando o 
envolvimento deste cluster no desenvolvimento cardíaco (Ventura et al, 2008). O 
envolvimento deste cluster em diversos processos de interesse deste estudo, poderá 
indicar que os microRNAs detectados podem participar no desenvolvimento cardíaco e 
serem potenciais agentes terapêuticos no futuro. 
A fim de se obter informação importante acerca dos processos celulares e redes de 
interacção em que estes estão envolvidos, particularmente na correlação com os perfis 
de expressão de microRNAs, foi também importante caracterizar os perfis de 
expressão génica de cada população. Este tipo de informação permitir-nos-á entender 
melhor a proveniência e destino das populações celulares alvo deste estudo, assim 
como perceber como o seu fenótipo é regulado por estas pequenas moléculas. 
Como já foi referido, a quantidade de material disponível revelou-se muito limitada, 
sendo necessário recorrer a técnicas direccionadas de qPCR, a fim de se quantificar a 
expressão de genes que já estavam referenciados como sendo importantes em 
processos biológicos, como a manutenção da estaminalidade celular e a diferenciação 
em células cardíacas. 
Fomos capazes de estabelecer as condições necessárias para proceder ao 
estabelecimento de perfis de expressão dos genes chave envolvidos na diferenciação 
cardíaca, mas infelizmente não foi possível obter amostras com quantidades 
quantificáveis de RNA.Os resultados obtidos para a quantificação dos genes algo 
usando o gene endógeno GAPDH como normalizador, revelaram um aumento da 
qualidade das amostras de RNA isoladas da população de células estaminais 
cardíacas. Foi também realizada uma quantificação para Pitx2 e GAPDH, que revelou 
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que as células estaminais cardíacas expressam Pitx2 ao nível de células do coração 
embrionário. Por esta razões, acreditamos que no futuro seremos capazes de 
aumentar a qualidade de RNA nas amostras e consequentemente estabelecer perfis 
de expressão para todos os genes alvo, procedendo assim a uma comparação 
efectiva entre as três populações em estudo. 
No futuro, será importante validar os resultados obtidos na expressão de miRs para 
amostras de populações celulares, num contexto de tecido preservado. Uma 
abordagem possível de detecção da expressão de microRNAs será a utilização de 
ensaios de hibridação “in situ”, recorrendo a técnicas de maior sensibilidade como o a 
utlização de LNAs (locked nucleic acid) (Obernosterer et al, 2007 and Silahtaroglu et 
al, 2007). 
Outros ensaios de manipulação funcional dos microRNAs podem ser também 
efectuados. Ao alterar a expressão génica através de antagonistas ou miméticos de 
mciroRNAs poderemos entender melhor o seu desempenho em processos de relevo e 
como agentes terapêuticos Estes ensaios constituem uma excelente oportunidade 
para revelar um pouco mais sobre os mecanismos de actuação dos microRNAs. 
Com este trabalho, fomos capazes de obter novas perspectivas sobre as populações 
celulares seleccionadas. Atendendo que a regulação de microRNAs se tem revelado 
de extrema importância ao nível do desenvolvimento e doença, nomeadamente a 
patologia cardíaca, esperamos que o identificarmos potenciais reguladores de 
estaminalidade e diferenciação desta população de células estaminais presentes no 
coração adulto, ter contribuído de forma significativa para um melhor conhecimento 
acerca deste assunto. 
 
Palavras-Chave: MicroRNAs, coração, células estaminais, doença cardíaca, 
desenvolvimento cardíaco 
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CPg - Cardiac Progenitor   
CSC – Cardiac stem cell 
c-kit - membrane stem cell factor receptor 
Ct – cycle threshold  
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EPr – Endothelial cell precursor 
ESC – Embryonic stem cells 
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Isl-1 – transcription factor islet-1 
MDR – membrane multi drug resistant 
miR – microRNA 
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mRNA – Messenger RNA 
qRT-PCR- Quantitative Real Time PCR 
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trna- Transference RNA 
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RIN- RNA Integrity Number 
RISC -  RNA – Induced silencing complex 
rRNA- Ribossomic RNA 
Sca-1 – Stem cell antigen -1 
shRNAS – Small hairpin RNAs 
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1. Introduction 
 
1.1. Stem cells: a concept 
 
Embryonic stem cells (ESC) and tissue stem cells (or adult stem cells) mediate tissue 
development and homeostasis. The first of these cell types is derived from the 
blastocyst and gives rise to the fetus. Several types of cells are generated during this 
process, like tissue stem cells and progenitor cells which eventually will give rise to 
every cell type in the organism (Suh et al, 2004). 
The hallmark of a stem cell is its ability to self-renew and to produce numerous 
differentiated cells, known as pluripotency. The self-replicating property, also known as 
self-renewal is achieved by a unique pattern of asymmetric divisions. This process 
gives origin to one daughter cell that retains stem cell properties (self-renewal and 
pluripotency) and another cell that may still divide, but whose differentiation fate is 
determined (Gangaraju and Lin, 2009). The divisions that occur during the 
phenomenon of self-renewal of stem cells are controlled by intercellular and 
intracellular mechanisms. On one hand, intercellular mechanisms include signaling 
from the neighboring natural microenvironment that supports stem cell behavior 
(niche). On the other hand, intracellular mechanisms involve differential gene 
expression, which is controlled at epigenetic, transcriptional, translational and post 
translational levels (Lin, 2008). These complex biological processes are coordinately 
regulated by a complex set of factors as ESCs have to shift to alternative molecular 
programs that inhibit self-renewal and promote the differentiated state.  
In order to characterize stem cells, distinct strategies have been developed. The large 
number of glycoproteins and carbohydrates that exist on the cell surface provides an 
excellent method for identifying these cells. On the surface of every cell are specialized 
proteins – receptors,that have the ability of selectively binding or adhering to other 
signaling molecules. Cells use these receptors as a way of communicating with other 
cells and to carry out their proper functions. Cell surface receptors are widely used as 
stem cell markers, as each type of stem cell displays a unique combination of receptors 
that makes it distinguishable from other kinds of cells (Rao et al, 2008). Some widely 
used stem cell specific markers include the stem cell antigen 1 (Sca 1) and c-kit 
membrane stem cell factor receptor , both present in the cell surface of stem cells. 
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1.2. The heart as a self renewing organ 
 
 
The old developmental paradigm established that the heart is a postmitotic organ 
incapable of regenerating parenchymal cells. Based on this view, loss of 
cardiomyocytes could not be compensated by entry into the cell cycle of a 
subpopulation of non-terminally differentiated myocytes or by activation of a pool of 
primitive cells that became committed to the myocyte lineage. The only response of 
cardiomyocytes to stress or injury was believed to be hypertrophy and/or death. It is 
now well established, that myocyte mitosis occurs in the fetal, neonatal, adult, and 
hypertrophied heart and that a pool of primitive, undifferentiated cells is present in the 
myocardium. This new paradigm suggests that myocyte formation is preserved during 
postnatal life, in adulthood or senescence, putting forward a different view of the 
biology of the heart (Anversa et al, 2006). The origin of this population of dividing cells 
remains unclear but various observations have raised the possibility that these cells are 
either the progeny of primitive cells of the bone marrow, which homed to the heart 
through systemic circulation, or represent the product of stem-like cells that originated 
from the remnants of the embryonic heart. However, the discovery of a population of 
cardiac stem cells (CSCs), distinct from hematopoietic stem cells (HSCs), argues 
against a significant role of the bone marrow in this process (Jackson et al, 2001). 
Thus, the heart contains a compartment of undifferentiated cells with the characteristics 
of stem cells, cardiac stem cells (CSCs) that give origin to different cell populations 
(Figure 1). Several studies have reported the identification of a class of human c-kit-
positive cardiac cells, which possess the fundamental properties of stem cells: they are 
self-renewing, clonogenic, and multipotent (Bearzi et al, 2007). Additionally, Sca1 
positive cells (Sca1 was reported as cell surface marker of hematopoietic stem cells) 
were identified in adult hearts and have some of the features of stem cells, like c-kit 
positive cardiac cells (Anversa et al, 2006). Other factors associated with 
undifferentiated progenitors have been identified in the heart like Isl-1, a transcription 
factor related to the commitment to the myocyte lineage during cardioblast 
differentiation (Laugwitz et al, 2005). Also MDR1, membrane multi drug resistant factor, 
which is expressed in several types of stem cells (Anversa et al, 2006). These different 
populations of heart progenitor cells have the ability to proliferate and to differentiate 
into beating cardiomyocytes in vitro, and also into other cardiac cells, as endothelial 
cells and vascular smooth muscle cells. 
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1.3. MicroRNAs – biogenesis and function  
 
miRNAs are small non-coding RNAs approximately 22 nucleotides in length that can 
regulate gene expression. This occurs through direct Watson-Crick base-pairing to the 
3’ untranslated regions of specific mRNA targets, mostly involving the 5’ region of the 
miRNA, known as the seed sequence. This interaction results in destabilization or 
suppression of the translation of the mRNA targets (Bartel, 2004;Ivey and Srivastava, 
2010). These small molecules are transcribed by RNA polymerase II and derive from 
precursor transcripts, called primary miRNAs (pri-miRNAs). These are first processed 
in the nucleus into an intermediate form (pre-miRNAs) by the microprocessor protein 
complex, which contains the Drosha and DiGeorge syndrome critical region gene 8 
(DGCR8 or Pasha) proteins. This process gives origin to hairpin-shaped precursors 
with 70 to 100 nucleotides in length. 
 
 
Fig.1 : Cascade of CSC growth 
and differentiation. Immature 
cardiac cells into four classes: 
CSCs, progenitors, precursors, 
and amplifying cells. The first 
three cell types express c-kit, 
MDR1, and Sca-1, whereas 
the last type no longer 
expresses these antigens. 
These cell types can be 
viewed as successive steps in 
the progressive evolution from 
a more primitive to a more 
differentiated phenotype: 1) 
asymmetrical division of a CSC 
into a daughter CSC and a 
daughter Cardiac Progenitor 
(CPg). 2) CPg gives rise to 
Myocyte Progenitor (MPg) and 
Precursor (MPr), Endothelial 
cell Progenitor (EPg) and 
Precursor (EPr), and Smooth 
Muscle cell Progenitor (SMPg) 
and Precursor (SMPr) cells. 
These cells in turn rise to the 
transient amplifying 
compartment, which can 
differentiate into endothelial 
cells, muscle cells and smooth 
muscle cells. 
Anversa et al; 2006 
 
 
1 
2 
 
 
MicroRNA and gene expression profiling of cardiac stem cells 
 
Ana Isabel Pinheiro                                                MBCB 09/10                                                                4 
 
Pre-miRNAs are exported by Exportin 5 from the nucleus to the cytoplasm where they 
are cleaved by Dicer, an RNase III-like enzyme into a 22 nucleotide duplex RNA 
molecule. This duplex is next integrated into the RISC (RNA induced silencing 
complex). During this process, one strand of the miRNA duplex is selected as a mature 
miRNA, while the other strand is degraded. Argonaute proteins play a crucial role in 
this process, as they are located in the RISC complexes and bind to single-stranded 
miRNAs (Meister et al, 2005) (Figure 2). The mature miRNA negatively regulates gene 
expression by either translational repression or mRNA degradation, depending on the 
sequence complementarity with its target mRNA (Lee et al, 2003). 
Recently, miRNAs have also been shown to be produced by two non-canonical 
pathways. In the first pathway, the first processing step is done by a spliceosome and a 
debranching enzyme, yielding a short hairpin that is ready for further processing by 
Dicer. These non-canonical miRNAs have been termed mirtrons. In the second 
pathway, short hairpin RNAs (shRNAs) are processed by unknown nucleases into pre-
miRNAs and are further processed into miRNAs by Dicer. miRNAs that have originated 
in  this way have been termed endogenous shRNA-derived miRNAs (Gangaraju and 
Lin,2009). 
Besides their role in the inhibition of the translation and promotion of mRNA 
degradation, miRNAs have also recently been shown to be capable to increase 
translation in case of cell cycle arrest and stress (Vasudevan et al, 2007). 
The first miRNA assigned to a specific function was lin-4, which targets lin-14 during 
temporal pattern formation in Caenorhabditis elegans. Since then, several hundreds of 
miRNAs have been discovered, each believed to regulate a large number target genes 
of many of which are involved in the regulation of processes like cancer, cardiac 
disease, among others (Bartel,2009).However, miRNA target identification and 
validation remains a major challenge in the field, as different bioinformatic prediction 
programs frequently predict different mRNA targets for individual miRNAs with a large 
number of false positive and false negative identifications (Williams et al, 2009). 
Target predictions by currently available bioinformatic methods, despite being very 
useful, usually end up relying on some pre-conceived knowledge of the miRNA 
function, as it is necessary to sort through hundreds of predicted targets in connection 
to the relevant biological knowledge to identify a limited set of significant targets to 
validate by functional approaches. (Cordes and Srivastava, 2009). 
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1.4. MicroRNAs in stem cell function and cardiovascular 
disease/development 
 
MicroRNAs have been identified as master switches controlling proliferation and 
differentiation events and, in particular, to function as key regulators of cardiac 
development and response to stress (Van Rooji and Olson,2007). 
The expression profile of miRNAs appears to be tissue or cell specific. This implies that 
a group of miRNAs expresses only in a certain tissue or cell type. The expression 
profile of miRNAs is also disease status dependent, as particular pathological 
processes have been found to be associated with the expression of a particular group 
of miRNAs, thus defining a signature expression pattern. These signature patterns 
could aid in the diagnosis and prognosis of human disease (Wang et al, 2008). 
Embryonic stem cells (ESCs) are known to be maintained by a set of key transcription 
factors which in turn directly regulate microRNA expression. An important set of 
transcription factors and RNA-binding proteins, like Oct4, Sox2, Nanog, Klf-4,c-Myc, 
Tcf3 and Lin28, cooperate in order to ensure appropriate ESC behavior. These 
 
Fig.2 – Biogenesis and 
function of microRNAs. 
Different events leading 
to translation inhibition 
(partial complementarity) 
or degradation of mRNA 
molecules by miRs 
(perfect complementarity) 
are represented.  
P-bodies are aggregates 
that constitute the site of 
mRNA decay and 
translation repression. 
Recently, chemically 
engineered 
oligonucleotides termed 
antagomirs have been 
developed to function as 
specific silencers of 
endogenous miRNAs.   
 
Adapted from Thum et al, 
2008 
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transcription factors can activate expression of ESC miRNAs and also play a role in 
silencing miRNAs expressed in differentiated cell types. (Martinez and 
Gregory,2010).There was also evidence that distinct miRNAs that are expressed in 
different cell types/cell stages, may be able to mediate stem cell self-renewal and 
differentiation. These miRNAs would have active roles and functions at different stages 
of the stem cell lineage, promoting or repressing differentiation. Several clusters of 
miRNAs are coordinately transcribed and this way give origin to distinct profiles of 
expression in distinct types of cells or stages of differentiation, acting as crucial 
regulators of stem cell functions. Therefore, the proliferation and differentiation of ESCs 
and various types of somatic tissue progenitor cells and germline stem cells are 
regulated by miRNA and this might be one of the most important emerging events of 
miRNA-mediated gene regulation (Gangaraju and Lin, 2009). 
Although the field of miRNA biology is still in its infancy, there is emerging evidence 
that miRNAs also play an important role in the pathogenesis of heart failure through 
their ability to regulate the expression levels of genes that govern cardiac development 
(Divakaran et al, 2008). Since the discovery of different miRNAs expressed in specific 
cell types, it was suggested that they may play important regulatory roles during 
cardiomyocyte differentiation, cell cycle, conduction and during stages of cardiac 
hypertrophy in the adult. This indicates that miRNAs may act as crucial regulators in 
controlling cardiac gene expression (Cordes  and Srivastava, 2009). 
There is evidence that various miRNAs control and/or modulate key components of the 
hypertrophic process in cardiac myocytes. This pathological condition is characterized 
by the increasing volume of this type of cells due to various disease conditions. Indeed, 
it has been shown that miR-1, miR- 18b, miR -133, miR-195, and miR-208 play crucial 
roles in modulating cardiac hypertrophic growth (Thum et al, 2007). miR-1 and miR-133 
are preferentially expressed in cardiac and skeletal muscle and have been shown to 
regulate differentiation and proliferation of these cells. Although miR-1 and miR-133 
form part of the same bicistronic unit, they are expressed as separate transcripts. Both 
miR-1 and miR-133 appear to play an important role in the remodeling of the heart that 
occurs during cardiogenesis. As an example, miR-1 is so important for the 
establishment of muscle identity that its mis-expression in fibroblasts is enough to 
transform their gene program (Divakaran et al, 2008). Another co-transcribed pair of 
miRNAs is miR-143 and miR-145. These miRNAs have been shown to act as key 
regulators of smooth muscle cells, which uniquely oscillate between proliferative or 
differentiated states (Ivey and Srivastava, 2010). 
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1.5. MicroRNAs as therapeutic tools 
 
MicroRNA functions are being revealed at an extremely rapid pace. These advances 
will not only lead to a better understanding of how miRNA mediated gene regulation 
contributes to the fate and behavior of stem cells, but should also shed light on the 
mechanisms through which miRNAs regulate a diverse spectrum of cardiac-related 
functions with developmental and pathophyosiological implications. Therefore, 
investigating the role of miRNAs in disease biology is a new frontier in biomedical 
research with great potential both as a therapeutic and diagnostic approach. 
Therapeutic manipulation of miRNAs represents a potentially powerful approach to 
treat cardiovascular and skeletal muscle diseases (Cordes and Srivastava, 2009). 
Modified antisense oligonucleotides targeting the mature miRNA sequence, antimiRs 
have already been shown to reduce the levels of pathogenic or aberrantly expressed 
miRNA (Van Rooji et al, 2008). Additionally, different strategies have already been 
developed in order to reconstitute the expression of a downregulated miRNA in a 
disease through the delivery of a miR mimic. This oligonucleotide contains a mature 
miRNA sequence and will act to repress the endogenous target genes. Therefore it is 
possible to obtain new insights of the cardiovascular disease process. 
miRNA-based therapeutics have several advantages when compared to the 
conventional drug approaches. As mentioned, miRNAs can regulate multiple 
components of the same pathway/cellular process, their targets are defined and their 
effects are better sustained and durable. Recently, one class of antimiR, a cholesterol-
modified antisense oligonucleotide, termed “antagomiR”, showed excellent efficacy in 
the inhibition of miRNAs following intravenous delivery in vivo. Chemical modifications 
and cholesterol conjugations have been shown to stabilize and facilitate the process of 
delivery (Thum et al, 2008) (Figure 2). In contrast to a genetic deletion, these 
oligonucleotides do not totally eliminate the targeted miRNA. Therefore, the remnants 
of the miRNA may be sufficient to sustain certain functions.  Additionally, antagomiRs 
do not affect the accumulation of pre-miRNAs, whereas most gene deletion strategies 
eliminate these sequences (Williams et al, 2009). However, new studies are still 
necessary to improve the delivery properties and to achieve successful in vivo 
scenarios (Van Rooji et al, 2008). 
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2. Main goals of this thesis 
 
In recent years several studies have identified stem and progenitor cells in the heart 
suggesting that this organ isn’t post mitotic. These new discoveries can change the 
understanding and therapeutic approach of heart diseases, opening new avenues in 
the field of cell therapy.  The origin of these cardiac stem cells remains at present 
unclear and little is known about the gene expression governing their proliferation, 
differentiation and renewal. It is already known that stem cell function and 
cardiomyocyte differentiation are finetuned by different genes and in particular 
microRNAs (miRs) have recently emerged as important players controlling cell fate and 
organ development, while providing signature patterns for the identification of specific 
cellular phenotypes (Wang et al,2008). 
The main goal of this thesis was to perform a comparative profiling of microRNA and 
gene expression patterns of cardiac stem cells that may contribute to elucidate their 
developmental origin. Additionally, we wanted to identify key regulators of stemness 
and differentiation of the stem cell population present in the adult heart, which may be 
used to manipulate cell fate in vivo. 
For this purpose, we have used the mouse as a model organism to isolate different cell 
populations including Sca 1 heart stem cells, bone marrow (lineage negative) cells as 
well embryonic heart cells (Embryonic Day 9) for comparative analysis. 
 
3. Materials and Methods 
 
3.1. Isolation of cell and tissue samples 
 
Mouse bone marrow c-kit positive lineage negative cells, heart sca1 positive cells and 
mouse embryonic hearts (E9) were used in this study according to the following 
procedures.  
Isolation of heart stem cells and bone marrow c-kit positive lineage negative cells was 
performed in collaboration with the team of Dr. Luis Rosário, Cardiac Regeneration 
Unit, Instituto Gulbenkian de Ciência, with technical support from the Cell Imaging Unit 
staff for FACS sorting. 
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3.1.1. Mouse Embryonic Heart Cells 
 
Balb/c mice were used for embryo collection. Females were sacrificed by cervical 
dislocation nine days after mating to harvest embryos at the desired stage – E9. 
Embryos were dissected in PBS buffer and hearts were collected, transferred to RNA 
later solution (RNAlater® #AM7020-Ambion) and stored at -80ºC. 
 
3.1.2. Heart Sca-1 positive cells 
 
Mouse hearts were dissociated to release different cell populations,  the resulting cell 
suspension that was labeled with anti-Sca1 and Sca1 positive heart stem cells were 
isolated by FACS sorting. 
Balb/c mice were sacrificed by euthanasia with CO2 asphyxiation and the hearts were 
removed and washed by injecting 1 ml of Hank’s Balanced Salt Solution (HBSS) 
without Ca2+ e Mg+ (Sigma-Aldrich). The hearts were sliced into small clumps (< 1 
mm3 ) in a microtube with 500ul of F12- Kaighn’s Media (F12-K) (GIBCO #21127) 
supplemented with 10% Fetal Bovine Serum (FBS - GIBCO), 3% 
Penicillin/Streptomycin (GIBCO #15140-122) e 1% Transferrin Sodium Selenite (ITSS) 
(Sigma-Aldrich
  # 1884) (F12-K+) and incubated at 37º C for 20 minutes with agitation 
(140 rpm). The tissue suspension was filtered through a 40µm nylon mesh at least 
three times in order to release the cells from the heart tissue. The cell suspension was 
centrifuged at 12000 rpm for 10 minutes at 4ºC and then the pellet was resuspended in 
1 ml of FACS buffer (HBSS and 5% FBS). A sample of isolated cells was counted with 
a hemacytometer, after staining with Trypan Blue solution (Fluka), in order to establish 
the viable cell count and the amount of antibody to use.  
For FACS (Fluorescent Activated Cell Sorting), cells were labeled with monoclonal 
antibody, anti-Sca1 (δ Mouse LY-6A/E, clone E13-161.7 Rat IgG2a – BD 
Pharmingen™#553355) conjugated with Fluorescein isothiocyanate (FITC). Staining 
was done at 4ºC in the dark for 30 minutes and washed with FACS buffer. Cells 
resulting from this procedure were sorted by flow cytometry - Fluorescence Actived Cell 
Sorting in a BD FACS Aria Cell-Sorting e FACSCalibur Cell-Analyzer System and Sca1 
positive cells were collected to a RNA later solution (RNAlater® solution #AM7020-
Ambion) and stored at -20ºC. An unstained sample (~1x106 cells) was prepared that 
acted as negative control for defining the gating parameters. 
MicroRNA and gene expression profiling of cardiac stem cells 
 
Ana Isabel Pinheiro                                                MBCB 09/10                                                                10 
 
3.1.3. Bone marrow c-kit positive lineage negative cells 
 
Balb/c mice were sacrificed by euthanasia with CO2 asphyxiation. The femur and tibia 
were removed and the bone marrow was collected by flushing with FACS buffer (HBSS 
and 5% FBS). The cell suspension was filtered through a 40µm nylon mesh and 
centrifuged at 12000 rpm for 3 minutes at 4ºC. Cells were washed once with FACS 
buffer and the cell pellet was resuspended with 1 ml FACS buffer.  
A sample of isolated cells was counted as described before in order to establish the 
viable cell count and the quantity antibody to use. For that propose, was prepared  a 
sample dyed with Trypan Blue solution – Fluka and several samples as a control 
(~1x106 cells each): unstained, CD5 conjugated with the fluorophore Phycoeritrine (PE) 
and c-kit – APC (δ Mouse CD117, clone 2B8 Rat IgG2b – BD Pharmingen™#553355). 
Cells were labeled with monoclonal antibody, Sca -1(δ Mouse LY-6A/E, clone E13-
161.7 Rat IgG2a – BD Pharmingen™#553355) conjugated with Fluorescein 
isothiocyanate (FITC). Staining was done at 4ºC in the dark for 30 minutes and washed 
with FACS buffer. 
For FACS (Fluorescent Activated Cell Sorting), samples were stained with FcBlock (δ 
Mouse CD16/32, clone 2.4G2 Rat IgG2b - IGC) for 15 minutes, at 4ºC and washed 
once. Staining was done with an antibody cocktail : B220-Bio (δ Mouse CD45R, clone 
RA3 6B2 Rat IgG2b - IGC), Mac1-Bio (δ Mouse CD11b, clone M1/70 Rat IgG2b – BD 
Pharmingen ™#553309), TER-Bio(δ Mouse TER 119/Erythroid cells, clone TER 119 
Rat IgG2b – BD Pharmingen ™#553672), GR1-Bio APC (δ Mouse Ly-6G/Ly-6C, clone 
RB6-8C5 Rat IgG2b – BD Pharmingen™#553125), CD5-PE (δ Mouse CD5, clone 53-
7.3  Rat IgG2a – BD Pharmingen™#553023), c-kit-APC APC (δ Mouse CD117, clone 
2B8 Rat IgG2b – BD Pharmingen™#553355)  for 20 minutes, at 4ºC,  in the dark and 
washed twice with FACS buffer. The last staining was done with SAV-PE (δ Mouse 
Streptavidin-Phyerythrin, clone Streptavidin – BD Pharmingen™#554061) for 20 
minutes, at 4°C, in the dark and the cells were washed twice with FACS buffer. 
Several control samples of ~1x106 cells each where prepared for setting the gating 
parameters for sorting: unstained, CD5-PE and ckit–APC. Finally, the cells were 
isolated by FACS as described before. 
 
 
 
 
 
MicroRNA and gene expression profiling of cardiac stem cells 
 
Ana Isabel Pinheiro                                                MBCB 09/10                                                                11 
 
3.2. MicroRNA Isolation, quantification and quality control 
 
Total RNA isolation from samples (including microRNA fraction) was performed with 
the mirVana miRNA Isolation Kit (Ambion - #AM1561), following the manufacturer’s 
instructions. 
Recovery of cells from RNAlater was performed by a centrifugation at 5000g, for 5 
minutes at 4ºC, removing the supernatant. Quantification of RNA was done with  
NanoDrop Spectrophotometer ND-100 (NanoDrop Technologies - Alfagene) and the 
samples were stored at -80ºC. 
Samples used for qPCR array analysis were further characterized in the Lab-on-a-chip 
2100 Bioanalyzer – Agilent using the pico6000 RNA chip for a more accurate 
quantification and evaluation of RNA preservation. 
 
3.3. MicroRNA Expression Profiling 
 
3.3.1. Stem Cell MicroRNA qPCR arrays  
 
The Stem Cell MicroRNA qPCR Array with QuantiMir TM (System Biosciences #RA 
620A-1) was used to quantify miRNAs present in the different cell populations by 
quantitative real-time PCR following the manufacturer’s instructions. This array 
includes probes for 95 known miRNAs and for the U6 snRNA as a housekeeping gene 
for normalization. The microRNAs probed in this array are reported to be involved stem 
cell renewal, hematopoiesis, neuronal development and tissue differentiation (Figure 
S1 - Stem Cell MicroRNA Array arrangement). This procedure involves tagging of small 
RNAs with PolyA polimerase followed by reverse transcription with an oligo-dT adaptor 
primer. miRs are then quantified by Real-Time PCR amplification with a universal 
reverse primer and a miRNA specific primer. All reagents required for anchor tailing 
and reverse transcription of small RNAs are supplied by the kit, in addition to the 
universal and miR specific primers. 
Reverse transcription reactions were performed according to the manufacturer’s 
instructions protocol on a Biometra T-personal 20 thermal cycler using a total RNA 
input ranging from 1 to 10 ng (as indicated) . Real-time PCR reactions were performed 
essentially according to the manufacturer’s indications using the recommended 2x 
SYBR Green qPCR mastermixes (Power SYBR Green PCR Mastermix # 43670659– 
Applied Biosystems) on a CFX Real Time System c1000 Thermal Cycler (BioRad) real-
time qPCR instrument. 
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Minor changes were done to the manufacturer’s protocol. The qPCR reaction was 
optimized for 20ul. Therefore, primers were resuspended with 28,6ul (100 µmol) for 
loading 2ul per well (0,35 µM per reaction). 
 
3.3.2. TaqMan qPCR probes 
 
TaqMan MicroRNA Assays (Applied Biosystems) are used for quantification of 
microRNAs and small housekeeping RNAs. The sno202 assay was used as a 
housekeeping gene for qPCR quantification of RNA samples. This two-step protocol 
consists of a reverse transcription reaction with a miRNA-specific primer, followed by 
qPCR based on TaqMan Assay chemistry using miR-specific primers and probes. For 
the reverse transcription reaction 1 ng of total RNA input (except for Sca-1 positive 
heart cells) was used as indicated by the manufacturer and run in a Biometra T- 
personal 20 thermal cyler (#050-550-Alfagene). qPCR assays were performed 
following the TaqMan MicroRNA Assays protocol on the CFX Real Time System c1000 
Thermal Cycler (BioRad) real-time qPCR instrument.  
 
3.4. Gene Expression Profiling 
 
Total RNA was isolated using TRI Reagent Solution (#AM9738 – Applied Biosystems) 
following the manufacturer’s instructions.Removal of genomic DNA from RNA samples 
was carried out using DNase I (Fermantas). Reverse transcription was done using the 
RevertAidTM H Minus First Strand cDNA Synthesis Kit (#K1631,#k1632 – Fermentas) 
with 1ug of RNA and oligo dT priming according to the manufacturer’s instructions. 
The PCR amplification of the cDNA products was performed with the DreamTaqTM  
DNA Polymerase (Fermentas) as follows: 95º C, 2min; [95ºC ,1 minute; 55ºC, 1 
minute; 72ºC , 1 minute]x 45 cycles; 72ºC, 5 minutes. This procedure was done in a 
Biometra T –Personal 20 thermal cycler ( #050-550 – Alfagene). Several mouse 
primers specific targeting genes with a role in cardiomyocyte differentiation were used 
as listed in the appendix (Table S1). 
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3.5. Data Analysis 
 
3.5.1 qPCR data analysis 
 
Analysis of qPCR array data was performed as follows. 
Raw Ct values were normalized by the quantile method using HTqPCR package 
(Dvinge and Bertone, 2009) implemented in Bioconductor (Gentleman et al. 2004). 
miRNAs which were outside the 90%CI were considered unreliable and miRNAs which 
had a Ct>38 for more than 3 libraries were considered undetermined and were not 
considered for further analysis. miRNAs with relatively constant Ct levels  are less likely 
to be differentially expressed, so including them in the downstream analysis would 
cause some loss of power when adjusting the p-values for multiple testing (the miRNA-
by-miRNA hypothesis testing). Variation across samples was assessed using the 
interquantile range values (IQR) for each miRNA. All miRNAs with an IQR below 1.5  
were filtered out.  
Clustering analysis was performed by estimating the euclidean distance between 
samples using gplots package of R. (http://cran.r-
project.org/web/packages/gplots/index.html). 
Analysis of differential expression was performed using lmfit function of Limma 
package of Bioconductor (Smyth, 2004). A conditional hypergeometric test algorithm 
(Benjamini-Hochberg procedure) was applied for correcting for multiple testing. 
 
 3.5.2. Functional Annotation 
 
Prediction of miRNA targets and functional annotation was performed using two 
independent approaches.  
The TargetScanTM web server (http://www.targetscan.org), developed by the Bartel 
group at the Whitehead Institute, was used to generate a list of predicted targets for 
selected miRNAs in mouse. The GoElite software tool (version 1.2 Beta - 
http://www.genmapp.org/go_elite/go_elite.html) was used to identify a minimal non-
redundant set of Gene Ontology biological terms or pathways that describe the list of 
targets using advanced over-representation analysis statistics to the mouse 
transcriptome. 
The GeneGo manually curated database (www.genego.com) and data mining tool 
(MetaCoreTM version 6.3) was used to analyse validated targets of the selected 
miRNAs, perform enrichment analysis for biological functions and pathways and build 
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networks of interactions for processes of interest like cell proliferation and 
differentiation within the biologically relevant context of cardiac related pathways and 
functions.  
 
4. Results 
4.1. Cell isolation and RNA extraction from selected mouse 
cells and tissues 
 
For the comparative profiling of Sca1 positive heart stem cells, we isolated samples 
from a stem cell population that has been already reported to have the ability to 
proliferate and differentiate into cardiac cells upon appropriate stimulation and which 
may represent one of the compartments from where heart stem cells can originate from 
bone marrow lineage negative cells. For this study, we additionally used samples 
derived from mouse embryonic heart from the ninth embryonic day. At this day, there is 
evidence of regionalization of the heart and emergence of cardiovascular vessels, 
corresponding to a stage of development when the cells have high rate of proliferation 
and aren’t totally committed yet. Also, this stage has some technical advantages since 
the heart is already visible and easily detached from the embryo. Adult heart stem cells 
have also been hypothesized to originate from remnants of this cell population. 
 
4.1.1 Sample isolation and spectrophotometrical quantification 
of RNA 
 
Embryo hearts were collected on three independent days (samples EMB1 to EMB3) 
from three different pregnant female mice. An average of 400 ng of total RNA per heart 
was obtained, allowing for direct spectrophotometrical quantification of the samples 
(Table 1). 
Three independent sortings of 100 000/115 000 bone marrow lineage negative cells 
were performed using bone marrow samples derived from single mice (BM1 to BM3). 
The concentration of RNA samples was below the sensitivity limits of 
spectrophotometrical quantification (2-3700 ng/µl) and required further evaluation by 
microfluidic approaches (see below). 
Isolation of Sca1 positive heart stem cells proved to be very challenging and required 
significant improvements in tissue isolation methods to increase both the number of 
cells sorted and the quality of the RNA isolated. 
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A significant improvement was reached in the number of cells sorted. Initially, cells 
sorted for culture reached values around 10.000 cells for sample. During our work, we 
were able to progressively increase the number of sorted cells in one order of 
magnitude (Table 1). The isolation of these cells is particularly difficult, as they 
represent a relatively small proportion of the cell populations in the adult heart, 
requiring extended sorting periods. Additionally, the heart is a particularly difficult tissue 
to dissociate. 
The improvements in isolation methods are patent in the number of hearts that were 
required to reach cell numbers in the range of 105. In the beginning, almost 30 hearts 
were used per sorting, but we were able to reduce this number to only 3 to 5 hearts 
and to obtain an improved yield in the number of cells and quality of RNA samples. 
These differences may also be related to the time associated with the procedure, as 
more hearts implicate more time in the extraction procedure. 
Three RNA samples (Sca 1.1 to Sca 1.3) isolated from heart Sca1 positive cells were 
used to generate the results presented in the following sections. As for bone marrow 
samples, they were found to be bellow the limits for spectrophotometrical quantification 
and required further evaluation by alternative approaches. 
 
 
 
  
 
Sample name RIN Total RNA (ng) Collected 
samples 
Emb 1 - 2075 5 hearts 
Emb 2 10 5989.5  15 hearts 
Emb 3 9 5570.04 12 hearts 
BM 1 9,5 126.2 100.000 cells 
BM 2 6,2 119.9 115.000 cells 
BM 3 5,7 101.4 100.000 cells 
Sca 1.1. 1 ND 100.000 cells 
Sca 1.2. 1 ND 200.000 cells 
Sca 1.3. 2,5 ND 600.000 cells 
Sca 1.4. - ND 400.000 cells 
Sca 1.5. - ND 500.000 cells 
Table 1 – RNA extraction data from different samples 
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4.1.2. Microfluidics Quantification and Quality Control – RIN 
 
In order to obtain an effective quantification and to verify the quality of the samples, a 
microfluidic analysis was done using the Agilent 2100 bioanalyzer with the pico6000 
RNA LabChip® Kit. RNA degradation was monitored by the behavior of the ribosomal 
band ratio 18S/28S. This quality control is based on the RIN (RNA Integrity Number) 
index, which ranges from 1 to 10, with 1 being the most degraded profile and 10 being 
the most intact. This index includes information from both rRNA bands and outside the 
rRNA peaks (potential degradation products) to provide a picture of the RNA 
degradation state. It can be used to directly compare samples and to ensure the 
reproducibility of gene expression experiments (Mueller et al, 2004). 
Different samples showed different values of RIN, indicating the RNA quality from each 
population (Table 1). We observed that embryonic mouse heart and the bone marrow 
samples presented high RIN values, indicating very good RNA quality, as exemplified 
in Figure 3. 
This approach also allowed the quantification of bone marrow derived RNA samples, 
which were found to be within the sensitivity range of the RNA pico6000 chip (500-
5000 pg/µl). Based on this data, we were able to determine an average yield of 0.368 
pg of RNA per cell (Table 1), which is in agreement with literature reported values for 
similar cells isolated by FACS sorting (Mack et al, 2007) 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
tRNA mRNA 
rRNA 
  
Fig.3 – Electropherogram of bone marrow sample performed on a pico6000 RNA 
LabChip® Kit using the Agilent 2100 bionalyzer  (500-5000 pg/ul) RIN =9.5 and 
RNA concentration=1,262 pg/ul 
tRNA 
mRNA 
rRNA 
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However, Sca1 samples were again below the quantification limit of this method and at 
least in one case presented an electropherogram pattern compatible with high RNA 
degradation, with very low RIN values (Figure 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although the RIN index is a valuable method to provide unambiguous assessment of 
RNA integrity, it cannot predict the usefulness of the samples for generating gene 
expression data without further analysis. A sample may be too degraded to perform a 
genome-wide microarray experiment, but can still deliver good RT-PCR data (Mueller 
et al, 2004). This is particularly relevant in the case of quantification of small RNAs, 
which have been shown to be very resistant to RNA degradation and to remain well 
preserved in samples that have very low RIN indexes (Szafranska et al, 2008) 
For this reason, we decided to perform a direct comparison of small RNA abundance in 
the different RNA samples that were isolated using a qPCR based approach. 
 
4.1.3 Relative Quantification of small RNAs by qPCR  
 
The main goal of this work was to obtain a microRNA and gene expression profile of 
heart stem cells, but early on we faced with significant difficulties in isolating good 
quality RNA samples. As previously referred, the amount of RNA in samples was very 
reduced, being below the quantification range of the most sensitive approaches. This 
may result from several aspects of the sample isolation methods, like the complex 
handling of cells and the time of the procedure of heart extraction and sorting, but may 
 
 
Fig.4 – Electropherogram of heart stem cells Sca1 positive performed on a 
pico6000 RNA LabChip® Kit using the Agilent 2100 bionalyzer  (500-5000 pg/ul) 
RIN = 2,5 and RNA concentration= 54 pg/ul 
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also be related to the specific cell type in question as, for example, we can achieve 
very good results from bone marrow sorted cells. These technical difficulties 
immediately warranted the use of qPCR as a highly sensitive profiling method, and 
excluded the application of microarray technology or other unbiased approaches for 
miRNA profiling such as cloning and sequencing.  However, before proceeding it was 
necessary to obtain evidence that the RNA samples from Sca1 positive heart cells 
attained a minimal quality for microRNA profiling. 
Small RNAs are very robust, often remaining preserved for many years, so they allow 
quantification even when RIN values are low and mRNA degradation is high. For this 
reason, we decided to perform a comparative analysis of small RNA abundance in 
samples using TaqMan microRNA assays (Applied Biosystems). These assays require 
low amounts of total RNA (1ng/reaction) representing in a context of samples with low 
values of total RNA, a highly sensitive procedure for relative quantification of small 
RNAs.  
To obtain a comparative profile of small RNA abundance in our samples we used the 
Taqman microRNA assay for the endogenous control sno202 and compared the Ct 
values obtained from 1ng of embryo and bone marrow RNA samples to the values 
obtained from a 5µl input of Sca1 positive heart samples (Table 2). 
Successive RNA samples derived from heart Sca1 positive cells were tested in parallel 
with the continuous improvement in cell isolation methods (data not shown) until we 
were able to reach Ct values for sno202 between 37.03 and 31.31. Comparison of 
these values with the average results obtained for 1ng of embryo or bone marrow 
derived RNA samples suggest total RNA levels between 0.83ng and 0.0129ng for Sca1 
samples (Table 2).  
As our preliminary assays suggested that these values were compatible with the 
sensitivity limits of the qPCR arrays which were selected for comparative miRNA 
profiling (see below), we decided to proceed to the characterization of miRNA 
expression in heart Sca1 positive stem cells. 
 
Sca1 + stem cells Ct values for sno202 Total RNA (ng) 
Sca 1.1 37.03 0.0129  
Sca 1.2 36.68 0.0259 
Sca 1.3 31.61 0.83 
Sca 1.4 33.58 0.2 
Sca 1.5 31.31 0.83 
Table 2 – Ct values for Sca1 positive heart stem cells samples and total RNA levels 
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4.2. Comparative miRNA profiling with focused qPCR arrays 
 
4.2.1 Array validation and experimental design 
 
In order to obtain a comparative microRNA expression profile between adult heart stem 
cells, lineage negative bone marrow stem cells and embryonic heart cells, a qPCR 
array plate that includes 95 known miRNAs and the U6 snRNA as a normalization 
signal - the Stem Cell MicroRNA qPCR Array with QuantiMiRTM (SBI – System 
Biosciences) was selected. This array provides an overview of the expression of 
several miRNAs that have already been described to be involved in stem cell and 
differentiation related processes and is compatible with the high sensitivity required to 
analyze our samples (Figure S1 – Plate array arrangement). 
To establish the reproducibility and sensitivity of this array a preliminary assay was 
performed, with different concentrations of the same embryonic heart sample, 1ng and 
10ng from the same dilution of cDNA. (full list of qPCR results is presented in Table 
S2).  As shown in figure 4, the results revealed a very good correlation between both 
assays and demonstrate that the array has enough sensitivity to work with low amounts 
of RNA. However, we noticed that a subset of primers revealed an abnormal behavior, 
displaying poor correlation between the sample concentration and number of cycles at 
the selected cutoff threshold. To identify primers that may be unreliable, we calculated 
the averaged ΔCt difference between the 1 ng and 10ng samples for all primers 
(expected: 2.5; observed: 2.69) and the corresponding standard deviation (Stdev= 
1.33). Twelve primers were found to have ΔCt differences outside the range of 0.5 
standard deviations of the average (2.1< ΔCt<3.4), and were thus considered to be 
potentially unreliable (list of potentially unreliable primers is presented in Table S3). 
This set of primers can be assigned to two distinct classes. On the one hand, we have 
primers that display the expected increase in Ct values from 10ng to 1ng RNA input 
(miR-367, let 7-b and miR-10a), but show a higher than expected variation in the ΔCt 
values. This may actually be due to technical errors during the assay setup. On the 
other hand, the subset of primers that display ΔCt values very close to zero or slightly 
negative (Table S3) are cause for bigger concern, as they seem to be producing a 
signal that is independent from the input sample. One explanation for this behavior may 
be the formation of primer-dimmers, although their melting curves presented single 
peaks. Considering that the maximum Ct observed in the assay was 39.5, we conclude 
that of the 9 primers with no amplification signal for one of the samples, six are within 
the average ΔCt range, and only three can be considered potentially unreliable (miR-
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17-3p, miR-20a and miR-146a; Table S3). These are the ones that show a low Ct value 
in the 1ng sample but did not produce any signal in the 10ng sample. In this case, the 
most likely explanation for this discrepancy is a technical error during plate setup. 
 
In order to evaluate the need for technical replicates, we performed two sets of assays 
using RNA samples from bone marrow lineage negative cells: a PCR replicate assay 
(Figure 7) and a RT replicate assay (Figure 8). The results show that the PCR 
replicates (same cDNA sample, independent PCR reactions) have a very high 
correlation (R2= 0,989), and thus technical replicates may be expendable in face of the 
high costs of each assay. However, the results from the reverse transcription replicates 
(same RNA sample, independent reverse transcription and PCR reactions) showed 
lower values of correlation (R2=0,842), thus revealing a much higher inter-assay 
variability. 
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Fig. 5 – Correlation between PCR replicates from the same reverse-transcription 
reaction of bone marrow RNA. Graph displays XY plot of Ct values obtained for 
each microRNA probe in independent real-time PCR reactions. R2=0.989 
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4.3. MicroRNA profiling 
 
 
 
 
 
The results obtained indicate that PCR replicates have a very high correlation 
generating robust results. Therefore, we considered technical replicates to be 
dispensable and decided for an experimental design choosing to perform three 
biological replicates of each sample. 
 
 4.2.2. Overview of sample miRNA expression profiles 
 
After establishing the miR qPCR array sensitivity and reproducibility, defining our 
experimental setup accordingly, we proceeded to determine the miRNA expression 
profiles of Sca1 positive heart stem cells and of bone marrow and embryonic heart 
control cell populations. Unfortunately, a delay in the shipment of the second set of 
arrays prevented us from obtaining results for the full range of samples defined in the 
experimental setup (three high quality biological replicates of each population) in time 
for inclusion in this dissertation. Therefore, in this section we present the results 
obtained with the first set of samples that could be analyzed, corresponding to the first 
three isolated Sca1 positive heart stem cells (Sca) of which two lack the desired 
quality, three samples of embryonic heart (Emb), and finally two samples of bone 
marrow lineage negative cells (BM), for which we have presented quantification and 
quality control data in section 4.1. The full dataset from qRT-PCR plate assays for each 
sample is presented in Table S2 in the appendix. 
As mentioned, our preliminary assays suggested that the values obtained for sno202 
quantification and estimated amounts of RNA were compatible with the sensitivity limits 
 
 
Fig. 6 – Correlation between reverse transcription replicates of the same bone 
marrow RNA sample. Graph displays XY plot of Ct values obtained for each 
microRNA probe in independent real-time PCR reactions. R2 =0,842 
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of the qPCR arrays, so we decided to proceed to the characterization of miRNA 
expression in heart Sca1 positive stem cells. Once we could not predict the exact 
quantity of RNA present in the Sca1 positive stem cells population, we decided to  
perform the assay with the maximum volume indicated (5ul) in case of this population. 
We have performed the assays for the other populations with 1ng of total RNA (0,2 
ng/ul). 
Once again, we were able to conclude that Sca1 positive stem cells population has 
lower quantities of RNA, since in two of the three samples we could not determine 
expression values for U6 snRNA and there was high number of probes without signal. 
The results obtained are summarized in Table 3. 
 
 
 
 Emb  
1 
Emb  
2 
Emb  
3 
BM  
1 
BM  
2 
Sca  
1.1 
Sca  
1.2 
Sca 
1.3 
Ct<38 52 51 63 64 54 18 19 40 
Ct=0 5 1 2 7 15 51 52 28 
Maximum 
Ct 
39.10 39.60 39.10 38.15 39.75 39.74 39.75 39.87 
Minimum 
Ct 
28.05 24.97 25.42 27.1 25.44 33.98 34.52 29.78 
Average 
Ct 
32.11 30.13 30.63 32.82 32.92 37.46 37.31 35.68 
U6 
values 
33.62 32.65 32.47 34.39 34.09 ND ND 33.72 
 
To obtain a preliminary overview of how the different biological replicates are behaving 
in the qPCR assays, we looked at the overall correlation between all samples, 
excluding the Sca1.1 and Sca1.2 samples due the low number of probes with 
determined signal (Figure 7). The results obtained show that samples with the same 
biological origin reveal good correlation of Ct values for all primers, reaching values 
above 0.81 for embryonic heart samples and of 0.73 for the two bone marrow samples. 
In contrast, correlation values for unrelated samples range from 0.37 to 0.58, with an 
average of 0.55. 
In order to verify how these similarities reflect the biological origin of the samples, we 
performed an unsupervised clustering analysis. As shown in Figure 8, the clustering 
algorithm was able to segregate the samples into three independent branches that link 
to their biological origin based solely on Ct correlation of raw data, suggesting that our 
dataset presents good internal consistency.  
 
Table 3 - Overview of qPCR data for each sample. Table presents the number of 
miRs with determined signal (Ct<38), undetected miRs (Ct=0), maximum, minimum 
and average Ct and U6 snRNA Ct values for each sample tested on qPCR arrays. 
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4.2.3. Comparative miRNA profiling 
 
As previously mentioned, the main goal of this work was to identify a heart stem cell 
signature profile that may provide clues to the origin of these cells and, in addition, to 
identify microRNAs that may be involved in the regulation of key stem cell functions.  
For this purpose we can, after normalizing the qPCR array data, 1) perform an 
unbiased clustering analysis to identify the main differences and similarities between 
 
Fig. 8 -  
Clustering 
analysis based 
on Ct correlation 
of raw data. 
Segregation of  
samples 
suggests good 
internal 
consistency. 
 
 
Fig. 7 – Graphic 
representation of 
the correlation 
between samples. 
Ct values derived 
from real time PCR 
assays using the 
microRNA profiling 
arrays (except Sca 
1.1 and Sca 1.2)  
Emb – Embryonic 
heart; BM - Bone 
Marrow; Sca 1 – 
Sample Sca 1.3 
Heart Sca 1 positive 
stem cells 
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the three cell populations under study; and 2) identify differentially expressed miRNAs 
between different samples. The low quality of two of the Sca1 positive heart stem cell 
replicates for which we obtained qPCR array data makes this analysis difficult, as it 
does not allow for sample normalization and statistical testing. Nevertheless, the data 
set presented here can still be explored as a preliminary approach to these questions, 
allowing the establishment of the approaches that will be used when the full data set is 
available. 
To take advantage of the available data on heart stem cells, we decided to look at the 
most highly expressed miRs in the sample replicates (Table 4). We were able to verify 
that all replicates were consistent allowing us to select the 5 most highly expressed 
miRs in this population. We also performed the same analysis for the embryonic heart 
and bone marrow lineage negative cells, revealing a similar degree of consistency to 
the observed in the Sca1 positive stem cells data. This suggests that samples of Sca1 
positive stem cells have good quality of RNA for miR analysis even though the 
abundance of RNA is reduced (Table 4). 
Each population shows a distinctive set of the most expressed miRs. It is noteworthy 
that the microRNAs that have been identified as most highly expressed in embryonic 
heart cells have been previously implicated in heart development, like miR-133a which 
is highly expressed in cardiac muscle cells and mir-20a, miR-19a and miR19b that 
encode miR 17-92 cluster. 
  
 
 
Heart Stem Cells Sca1 positive 
Sca 1.1. Sca1.2. Sca 1.3. 
MicroRNA Ct value MicroRNA Ct value MicroRNA Ct value 
miR-206 33.98 miR-125a 34.52 miR-126 29.78 
miR-125a 34.49 miR-126 34.59 miR-125b 30.07 
miR-126 34.56 miR-146b 34.80 miR-23a 31.15 
miR-23a 34.65 miR-125b 35.12 miR-23b 31.51 
miR-125b 34.86 miR-23a 35.43 miR-133a 32.00 
miR-146b 35.82 miR-25 35.68 miR-125a 32.14 
miR-127 36.02 miR-193b 35.72 miR-26a 32.27 
miR-23b 36.41 miR-26a 36.19 miR-30c 32.59 
Bone Marrow 
BM 1 BM 2 
MicroRNA Ct value MicroRNA Ct value 
miR-223  27,24 miR-223  25,44 
miR-92  27,90 miR-92  26,10 
Table 4 – MicroRNAs with highest expression values from the different qPCR 
assays for each cell population. 
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miR-23b  28,38 miR-16 27,24 
miR-25 28,42 miR-20 a 27,26 
miR-20 a 29,01 miR-93 28,00 
miR-191  29,24 miR-106 a 28,08 
miR-16 29,47 miR-30c 28,34 
miR-19b 29,75 miR-30d  28,36 
Embryonic Heart 
Emb 1  Emb 2 Emb 3 
MicroRNA Ct value MicroRNA Ct value MicroRNA Ct value 
miR-19 b 28,05 miR-19b 25,42 miR-19a 24,97 
miR-19 a 28,21 miR-19 a 25,68 miR-19b 25,01 
miR-133 a 28,30 miR-133 a 25,80 miR-20a 25,53 
miR-30c 28,36 miR-20 a 25,91 miR-133a 25,55 
miR-126 28,44 miR-30c 26,29 miR-20b 25,90 
miR-92  28,49 miR-20b 26,30 miR-106a 26,01 
miR-106 a 28,55 miR-106 a 26,39 miR-30b  26,20 
miR-16 28,66 miR-133b 26,71 miR-30c 26,36 
 
To identify miR signature profiles in each sample, we performed an unsupervised 
clustering analysis of miR expression after data normalization (Figure 9). All arrays for 
embryo and bone marrow samples and for the heart stem cell sample Sca1.3. were 
included in this analysis.  
After performing a clustering analysis of miR expression, we could verify that biological 
replicates were clustered in independent branches, confirming the internal consistency 
of our data. Each cell population has a distinctive miR expression profile, and clusters 
of miRs that distinguish heart embryo cell from bone marrow stem cells can be clearly 
identified. 
We could observe that a characteristic set of microRNAs is associated with embryonic 
heart population (Figure 9 – grey line) and another individual set of microRNAs is 
associated with bone marrow cell population (Figure 9 – blue line). Even though some 
of the miRs are coincident for both samples (Figure 9 – yellow line), we could observe 
a distinctive profile for each population. We verified that some of the miRs with higher 
expression in the embryonic heart have already been reported to be involved in several 
processes of cardiac development, like miR-133a. Also, we have noticed high 
expression of miRs like miR-19a, miR19b, miR-18a, miR17-5p that are reported to 
constitute the cluster 17-92 (miR-20a can also be included, however isn’t clustered to 
the other miRs due to a technical error in EMB1 sample).  
The heart stem cell population was clustered in the same branch as bone marrow stem 
cells (Figure 9 – green arrow). This may reflect the origin of the heart stem cell 
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population, although in spite of this clustering with bone marrow stem cells, its miR 
expression profile appears to be a mixture of embryonic heart and bone marrow 
population and this is thus quite distinctive (Figure 9 – purple line). These differences 
may reflect the quiescent or the highly proliferative phenotype that these cells may 
present and which are characteristic of the bone marrow cell population and the 
embryonic heart, respectively. This kind of analysis may allow us to obtain new insights 
about the origin and gene expression signature of these cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to identify differentially expressed miRs, pairwise comparisons between miR 
expression data from two cell populations can be performed. However, this approach 
can be only applied for samples with replicates for significant statistical analysis. 
 
Fig. 9 – Unsupervised clustering analysis of samples and normalized miR 
expression values.  
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Therefore, this analysis could not be performed for heart Sca1 positive cells. 
Nevertheless, we chose to apply the method to identify differentially expressed 
miRNAs between the heart embryo and bone marrow lineage negative cells. In the 
future, with new samples, we will be able to perform this comparative study between all 
populations. 
We carried out the comparison between embryonic heart and bone marrow cell 
populations using normalized qPCR array expression data (Figure 10). 
31 microRNAs showed differential expression between the two samples, of which 
nineteen were overexpressed in the embryonic heart and the remaining twelve were 
overexpressed in bone marrow stem cells. 
The microRNAs miR-133a and miR-133b, found to be overexpressed in the heart 
embryo, have been previously reported to be key regulators of heart differentiation 
(Ivey and Srivastava, 2010). Additionally, we have identified as differentially expressed 
a cluster of microRNAs (miR-19a, miR-19b, miR-18a and miR-17-5p) for which there is 
a single report of involvement in heart function (Ventura et al, 2008). Strikingly, this is 
the same cluster that was identified like being highly expressed in the embryonic heart, 
which may indicate that the detected miRs can be involved in the regulation of heart 
development.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10 –Comparison between miR expression data from embryonic heart and 
bone marrow populations, using normalized qPCR array data. miRs with log10 
(RQ)>0 are overexpressed in bone marrow cell population. miRs with log10(RQ)<0 
are overexpressed in the embryonic heart. 
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4.3. Functional Annotation 
 
The identification of signature and differentially expressed miRs can be correlated to 
specific cellular functions by performing a functional annotation of known and predicted 
miR targets. Although, we do not have a complete data set for the characterization of 
Sca1 positive heart stem cells we were able to identify a set of microRNAs that is 
highly expressed in these cells from the analysis of qPCR data. Therefore, we decided 
to address the question of which cellular functions may these microRNAs be regulating 
and how do they correlate with phenotype of these cells. This kind of approach involves 
several stages of work and the amount of information originated is not manageable to 
include within the limits of this thesis. Therefore, we will only present examples for 
some of the results obtained, but all the microRNAs referred were or will be the subject 
of a similar study. 
Two complementary approaches were used for functional annotation of miRNAs 
identified in Sca1 positive cells. 
In order to identify the predicted targets of the top five miRs, the TargetScanTM 
database was used. This list of targets was then analyzed with the GoElite software 
(version 1.2) to identify enrichment for cellular processes and pathways (see Table S4 
in appendix for list of targets and processes). The results of this analysis reveal that the 
lists of predicted targets for miRNAs that were identified as highly expressed in heart 
stem cells are significantly enriched in genes that are involved in processes that are 
highly relevant for the function of this cell type. In particular, we have found that the 
targets of miR-125a are mainly involved in processes like positive regulation of 
transcription factor activity and blood vessel development. Also, the targets of miR-126 
are involved in relevant processes like regulation of gene expression, stem cell 
differentiation, response to DNA damage stimulus, organ growth, among others.  
This analysis allowed us to identify predicted miR targets that are associated with 
relevant cellular functions, thereby defining a subset of potentially relevant genes that 
may be the subject of future functional studies. 
In an alternative approach, we took advantage of the manually curated GeneGo 
Database (MetaCore TM) to identify validated targets and regulators of the selected 
miRNAs and correlate them with gene networks relevant for the control of cell 
proliferation and differentiation of cardiac cells. For this purpose, we established the 
systematic workflow depicted in Figure 10. 
First, the GeneGo Database was used to retrieve validated targets and regulators of 
each of the top-five miRNAs identified in heart stem cells. Table 5 lists the genes that 
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are annotated in the database, as well as the biological processes that they are related 
to. Again, quite strikingly, many of them are correlated with processes that are 
extremely relevant for heart stem cell function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-23 a Processes 
c-Myc Inhibits Cell cycle progression/apoptosis/cell transformation 
ESR1 Activated by Regulation of gene expression/cell proliferation and differentiation 
MuRF1 (Tri63) Activated by Degradation of cardiac troponin/muscle atrophy and hypertrophy 
SDF-1 Inhibited by Proliferation of bone marrow-derived b progenitor cells 
miR-23b Processes 
c-Myc Inhibits Cell cycle progression/apoptosis/cell transformation 
ESR1 Activated by Regulation of gene expression/cell proliferation and differentiation 
HGF receptor (Met) Inhibited by Cell proliferation and morphogenesis 
NOTCH1 percursor Inhibited by Differentiation, proliferation and apotosis/cell specification 
RelA (TF65) Activates Cell growth/differentiation/tumorigenesis/apoptosis 
SMAD 3 Inhibited by Development of tissue 
SMAD 4 Inhibited by Gastrulation 
SMAD 5 Inhibited by Angiogenesis 
miR-125a Processes 
Lin-28 Inhibited by Supressor of miR biogenesis/Maintenance ES cells 
Lin-41 Inhibited by Control of organ formation during development 
PEA3 (ETV4) Inhibits Regulatory work during embryogenesis 
miR-125b Processes 
Ajuba (Jub) Inhibited by Control of cell determination/differentiation/proliferation/cell adhesion 
Androgen Receptor Activates Regulation of gene expression/cell proliferation and differentiation 
Table 5 – List of microRNAs from heart stem cells sca-1 positive, of the main 
predicted targets and regulators and associated processes 
Fig. 10 – Workflow of analysis with GeneGoTM(MetaCore)  software. Different filters 
can be introduced in order to include other processes and regulators of interest. 
GeneGo™
(MetaCore) 
Software
Validated targets of microRNAs from each cell population
Enrichment Analysis
Processes
Cell
Differentiation
Conection with most important
validated targets from each miR
Build network processes for cell proliferation
/differentiation in the heart:
• Cardiac muscle cell proliferation/differentiation
•Regulation of cardiac muscle cell proliferation
/differentiation
•Cardioblast proliferation/differentiation
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BMF Inhibited by Apoptosis 
PARF Inhibited by Enhances cell proliferation 
CDK6 Inhibited by Control of cell cycle 
Lin-28 Inhibited by Supressor of miR biogenesis/Maintenance ES cells 
Lin-41 Inhibited by Control of organ formation during development 
TBC1D1 Inhibited by Cell cycle and differentiation 
miR-126 Processes 
Androgen Receptor Inhibits Regulation of gene expression/cell proliferation and differentiation 
c-Rel Activates Cell growth/differentiation/tumorigenesis/apoptosis 
PLK2 Inhibited by Role in embryogenesis 
SPRED1(SPRE) Inhibited by Negatively regulates hematopoiesis of bone marrow 
VEGF-A Inhibited by Vascular growth factor 
Next, we used the software's enrichment analysis tool in order to obtain an unbiased 
identification of the cellular processes that show a statistically significant enrichment in 
this list of genes (Figure 11). This analysis confirmed that the miRNAs that were 
identified in our assays are likely involved in the regulation of key processes for heart 
stem cell function, as the key processes identified link them to cell proliferation and 
differentiation and regulation of development 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Simply by selecting one of the functions identified in the enrichment analysis output, it 
is possible to obtain a network of interactions depicting the most relevant associations 
found by the software for the specific process. The network of interaction for the 
process of cell differentiation (number 5 – Figure 11) for miR 23b which was the miR of 
the higher pvalue, represented by the red bar (Figure S2- network of interaction for cell 
differentiation,miR-23b). 
 
Fig. 11 - Enrichment analysis of top five miRs of Sca-1 positive cell population 
Representation of the main processes. Each rectangle corresponds to a different 
microRNA, miR-23a: orange; miR-23b:red;miR125a-5p:blue;miR125b-5p:green 
and miR-126:olive green. 
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In parallel, taking the validated targets of each microRNA it was possible to build 
different networks of interaction that connect the selected miRs to cellular processes or 
functions of interest, independently of the results of the enrichment analysis. These 
networks connected the different targets from each list, allowing us to understand the 
involvement of each target in the different processes and to generate testable 
hypothesis regarding the function of the miRs in these cells, which may be explored in 
future work. (Figure 12 /13) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.13 – Interaction network interaction for cell proliferation. miRNA targets are 
highlighted with a red dot (see appendix Table S5 for details) 
 
 
Fig.12 – Interaction network interaction for cell differentiation. miRNA targets are 
highlighted with a red dot (see appendix Table S5 for details) 
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After building these networks for cell differentiation and cell proliferation in the heart, 
we verified the presence of several important genes that are reported to been involved 
in processes of interest. Among others, we observed the presence of ESR1, which is 
involved in the regulation of gene expression and Notch1 precursor that is involved in 
cell specification and cell differentiation, both contributing for the functions developed 
by heart stem cells. This indicates that the targets of the miRs with higher expression in 
the heart Sca1 positive stem cell population develop important roles in many processes 
that are essential for the heart stem cells function, providing additional information 
about this cell population. 
 
4.4. Gene Expression Profiling 
 
Characterization of gene expression profiles can provide important information about 
the cellular processes and interaction networks which they are involved in, particularly 
in correlation with the expression profiles of their microRNAs regulators. This kind of 
information can allow us to understand the origin and fate of the cell populations under 
study and how their phenotype is finedtuned by these small molecules and the 
regulatory networks they establish. Ideally, gene expression profiles can be obtained at 
the genome wide level using microarray technology. However, when the available 
material is very limited, alternative, more focused qPCR based procedures can be 
adopted in order to quantify the expression of genes that are already known to be 
important markers of relevant biological processes. In our particular case, these will be 
genes involved in stem cell maintenance and cardiac cell differentiation.  
Previous work from our group, in collaboration with the Cardiac Regeneration group, 
established a set of 25 genes known to be key regulators of these processes based on 
a literature search. Primers for qPCR amplification of the corresponding cDNAs were 
designed and tested using mouse heart and bonemarrow cDNA samples (Rasteiro, M., 
Marinho, S. et al, unpublished data; see Appendix Table S1 and Figure S3). However, 
in these preliminary assays no PCR products were obtained for six of the target genes: 
Isl1, Nkx25, Mef2C, Hand, Cited and Irx5. 
In order to understand the reason for this failure, we started by serching the BioGPS 
gene portal (http://symatlas.gnf.org), a gene annotation database that encodes 
information about the expression of the genes of interest in different tissues (Su et al, 
2004). The tissue references retrieved are presented in the Appendix Table S1. The 
results from this analysis, together with a careful review of the literature on these genes 
suggested that they might not be expressed to high levels in the two mouse tissues 
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tested, as they are mostly involved in early heart developmental processes. For this 
reason, we decided to test this subset of primers using the total RNA samples that we 
isolated from mouse embryonic heart (E9). As shown in Figure 14, we were able to 
obtain good RT-PCR signals for all the primers that had previously failed. These 
primers were additionally tested in Real-Time PCR assays using more stringent 
annealing and amplification conditions and where found to have high specificity and 
amplification efficiency. 
 
 
 
 
 
 
 
 
Thus, we were able to set up the conditions required to perform a focused qPCR 
expression profiling of key genes involved in cardiac cell differentiation, which are 
expected to provide important data for the characterization of the heart stem cell 
population under study. Unfortunately, until the end of this thesis work we were unable 
to obtain samples from these cells with quantifiable amounts of RNA and, in 
consequence, we were unable to obtain data regarding mRNA preservation, which is 
essential before embarking in very expensive qPCR assays. Nevertheless, we decided 
to perform preliminary assays on the available samples by qualitative RT-PCR of 
several of our target genes, using the endogenous GAPDH mRNA as housekeeping 
control. The results obtained show a consistent improvement in the quality of RNA 
samples isolated from cardiac stem cells, in agreement with what we observed for 
microRNAs (data not shown). Although the total amount of RNA was still below 
quantification, we were able to obtain RT-PCR signal for several target genes, as 
exemplified in Figure 15.  
 
 
 
 
 
 
 
 
Fig.15 – RT-PCR amplification of selected genes from different samples of each 
population: embryonic heart (Emb), cardiac stem cells (CST) and bone marrow 
(BM) for a marker of cardiac development Pitx2 (145bp) and housekeeping gene 
GAPDH (86 bp). A 50 bp ladder was run in the first lane. Size range between 50bp 
and 250bp is shown. 
 
    
 
 
 
 
 
Fig.14 – RT-PCR amplification of selected genes from embryonic heart RNA 
samples. Expected amplicon size: Isl 1 (171 bp), Nkx25 (166 bp); Mef2C (194bp); 
Hand (197bp); Cited (147bp); Tbx2 (152 bp) and Irx5 (127bp). A 50 bp ladder was 
run in the first lane. Size range between 50bp and 250bp is shown. 
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Thus, we were able to establish the basic procedures to obtain focused gene 
expression data to compare heart stem cells with the two control cell populations 
selected for this study (embryonic heart tissue and bone marrow stem cells) as soon as 
the quality of the RNA samples reaches the minimal threshold for evaluating mRNA 
preservation. We expect that this will generate important data for the phenotypic 
characterization of these cells and for the identification of active regulatory networks 
related to maintenance of stem cell function and inhibition of proliferation/differentiation. 
As a first overview, we performed a densitometric quantification of the data presented 
in Figure 15 for Pitx2 and GAPDH, in order to compare the expression profiles of the 
three cell types tested (Figure 16). Although very preliminary, the results obtained 
suggest that cardiac stem cells express the Pitx2 mRNA at a level that is closer to the 
one observed in the embryonic heart than to bone marrow stem cells. 
The results that were obtained during the course of this work suggest that we will be 
able to significantly improve the quality of our RNA samples so that a quantitative 
qPCR profiling can be performed for all these genes producing a more detailed 
comparison between the three cell populations under study. 
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Figure 16 -   Comparison of the expression profiles for Pitx2 (normalized to 
GAPDH) of embryonic heart (Emb), cardiac stem cells (CST) and bone marrow 
cells (BM) performed by densitometry of RT-PCR.  
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5. Discussion 
 
The main goal of this thesis was to identify novel regulators of stemness and 
differentiation of the stem cell population present in the adult heart, which may be used 
to manipulate cell fate in vivo for therapeutic purposes. 
Recently, microRNAs have been identified as master switches controlling proliferation 
and differentiation events and, in particular, to function as key regulators of cardiac 
development and response to stress. This way, the study focused on the microRNA 
expression profile of each cell population, in order to identify and understand in a better 
way the active gene expression regulatory networks governed by these small 
molecules. 
For this study Sca1 positive heart stem cells were isolated from adult mouse hearts 
and two suitable cell populations were selected for comparison purposes: bone marrow 
lineage negative cells and mouse embryonic hearts (E=9). Both of these cell types 
have been reported to have the ability to differentiate into different cell types like 
cardiac cells, but are distinctive in their proliferation activity, as bone marrow cells are 
quiescent, while embryonic heart cells have a high rate of proliferation.  By comparing 
these cells with heart stem cells, we wanted to unveil a little more about their origin, 
namely, to obtain evidence in support of an origin in the bone marrow and then 
migration into the heart or if they are actually generated in the heart forming niches 
(Urbaneck et al, 2006). Additionally, we expected these comparative profiles to provide 
clues into regulatory networks controlling active cell proliferation and commitment into 
cardiac cell lineages, both of which are active in the embryonic heart, or into cellular 
quiescence and maintenance of stem cell profiles, which is a hallmark of bone marrow 
stem cells. By comparing their microRNA profiles we expect not only to obtain evidence 
on what is the provenience of the cells, but also which microRNAs are important for the 
maintenance of the cell state/fate. 
As a first step towards our goals, it was necessary to improve the methods for isolation 
of the cell populations and RNA extraction, based on the approaches that had already 
been set up by the Cardiac Regeneration Unit for the establishment of in vitro stem cell 
cultures and their differentiation into distinct types of cardiac cells.  
The first concern was the quality of the RNA extracted from the samples. The 
miRvanaTM miRNA Isolation Kit was chosen because, in contrast with other more 
conventional procedures based on phenolic extraction or column retention followed by 
alcoholic precipitation, it isolates the total RNA fraction preserving small RNAs, like 
microRNAs, for further analysis. This method had to be coupled to a FACS 
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(Fluorescent Activated Cell Sorting) approach, for the purpose of selecting the cells of 
interest in a direct way (Baerzi et al, 2007). 
In order to obtain an effective quantification and to verify the quality of the samples in 
agreement with the most recent standards for gene expression profiling (Mack et al, 
2007), an analysis using the Agilent 2100 Bioanalyzer with a pico6000 RNA LabChip® 
Kit was performed. The derived RIN (RNA Integrity Number) value acts as a quality 
control once it translates the state of degradation of the RNA present in the samples. 
This method was selected since provides a direct system for comparing samples, 
ensuring the reproducibility of the assays (Mueller et al, 2004). 
Although we were able to obtain high quality samples from both isolated embryonic 
hearts and FACS sorted bone marrow cells, we faced extreme difficulties in the 
isolation of good RNA samples from heart stem cells. This can be explained by the 
complex handling of cells and the time of the procedure of heart extraction and sorting. 
In this context, a significant effort was put during the whole period of this work to 
improve the quality and quantity of RNA extracted from these samples, once these 
parameters were bellow the minimum required expectations. Therefore, we were able 
to increasingly improve the methodologies for cell and RNA isolation until, by the end of 
this work our Sca1 positive heart stem cell samples were found to generate qPCR 
amplification profiles for the housekeeping gene sno202 comparable to those obtained 
with 1ng of RNA from embryonic heart samples. This corresponds to an RNA 
concentration that is still very close to the lower detection limit of the Agilent 
Bioanalyzer (500-5000pg/µl), and is thus very difficult to analyze for quantification and 
RNA degradation. Thus we are still very far away of the quality thresholds required for 
large scale gene expression profiling. However, these improvements were already 
within the range of sensitivity of the assays that we established to quantify miRNA 
expression levels, and thus we were able to obtain a preliminary profile for Sca1 
positive heart stem cells from some of these samples.  
MicroRNAs are particularly appropriate markers for molecular characterization since 
they are less prone to degradation and modification when compared to mRNAs 
(Doleshal et al, 2008). Studies of microRNA expression with samples up to ten years 
have been reported, showing the reproducibility and accuracy of the assays involving 
these molecules (Szafranska et al, 2008). Several approaches for detection and 
quantification of microRNAs are being developed, but some of them cannot be 
performed in case of low amounts of RNA. This can be said of microarray technology, 
despite the recent advances in reproducibility and high sensitivity, but also of other 
procedures like Northern hybridization, cloning and sequencing approaches. For this 
reason, qRT-PCR based methodologies were adopted in this study in order to evaluate 
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miRNA expression levels: the TaqMan microRNA assays (Applied BioSystems) and 
the Stem Cell microRNA qPCR assay with Quantimir (Systems Biosciences), both of 
which revealed high sensitivity and robustness for detection and quantification of 
microRNAs in our low abundance samples. 
Next, we proceeded to establish the microRNA expression profile from each 
population. Using a specific set of microRNAs included in a 96 plate array with reported 
functions in stem cell and tissue differentiation, we were able to verify that each 
population had a distinct profile.  
In order to obtain insights into the origins of the stem cell population was performed a 
comparative analysis between mouse Sca1 positive cell population, bone marrow 
lineage negative cells and mouse embryonic heart (E=9). A subset of microRNAs with 
relative high expression levels in Sca-1 positive cells was identified: miR-126; miR-
125a; miR-125b, miR-23b and miR-23a (Table 4). These miRs seem to be involved in 
different processes of interest, targeting several genes that regulate the heart stem 
cells functions. 
In order, to address the question of which cellular functions may these microRNAs be 
regulating and how they correlate with the phenotype of these cells, we performed two 
complementary approaches for functional annotation of miRNAs identified in heart 
Sca1 positive stem cells.  
This way, to identify the predicted targets of the selected miRs, the TargetScanTM 
database was used. This list of targets was then analyzed with the GoElite software 
(version 1.2) to identify enrichment for cellular processes and pathways. This analysis 
revealed that the targets of the highly expressed miRs in the heart Sca1 positive stem 
cells, are involved in processes like regulation of the transcription factor activity,  blood 
vessel development , stem cell differentiation and organ growth, in case of the targets 
of miR-125b and miR-126. The targets of miR-23a, miR-23b are implicated in 
processes like DNA damage checkpoint and the correspondent targets of miR-125a 
are associated to processes of cell recognition.  
The other approach was performed using the GeneGo Database (MetaCore TM) to 
identify validated targets and regulators of the selected miRNAs and correlate them 
with gene networks relevant for the control of cell proliferation and differentiation of 
cardiac cells. Once again, we were able to verify that many targets of the selected 
miRs were correlated to different processes that have crucial roles in the heart stem 
cell function. After building the networks for cell differentiation and cell proliferation in 
the heart, we verified the presence of several important genes that are reported to 
been involved in processes of interest. In parallel, an enrichment analysis was 
performed and the results pointed in the same direction, showing that the targets and 
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regulators of the selected miRs may play crucial roles in different processes like cell 
differentiation. 
Even though these two approaches have different bases, they act as complement of 
each other. Enrichment analysis is based on the software alone, comparing the 
different lists of targets with the genome of the target organism and electing the most 
statically significant targets for each process of interest. On the other side, analyzing 
individual processes allowed us to identify which targets were involved in each specific 
process, directing the analysis. This way, both approaches act for the same propose, 
providing information about the different targets of the most expressed microRNAs in 
the heart stem cell population and the processes involved, giving new insights about 
this type of cells. 
This kind of approaches, despite being very useful rely on some pre-conceived 
knowledge of the miRNA function to sort through the hundreds of predicted targets. 
Although this tool revealed to be very useful is necessary to improve some aspects of 
this analysis. Several stages of work were performed and even though we have 
already reached important information it will be crucial to better understand the data 
extracted from this software. 
This comparative analysis performed between the three populations revealed that the 
overall expression profile of Sca-1 positive cells was closer to bone marrow cells, which 
may reveal the origin of these cells, but the most highly expressed miRs in Sca-1 
positive cells were distinctive. Its miR expression profile appears to be a mixture of 
embryonic heart and bone marrow population, constituting a distinctive miR expression 
profile. 
Together, these results allow us to think that we are stepping towards a very interesting 
direction. If we manage to modulate these highly expressed miRs in cardiac stem cell 
population which are involved in such great number of relevant processes, we may be 
able to manipulate the fate the cardiac stem cells and in this way, eventually modulate 
their phenotype for regenerative purposes. 
Attesting to the robustness and biological relevance of our data, several of the miRs 
detected in the bone marrow cell population and in the embryonic heart have already 
been reported in distinct but highly connected biological settings. For example, miR-
133a found to be highly expressed at the embryonic heart (see table 4), consistent with 
the knowledge that miR-133a is expressed in cardiac muscle cells (Ivey and 
Srivastava, 2010). Also, miR-133a is implicated in cardiac disease once its reduced 
expression may lead to cardiac hypertrophy. Together, these studies show the 
importance of this microRNA and the significance of its high expression in our study. 
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Interestingly, a subset of microRNAs that were also detected in embryonic heart may 
integrate miR-17-92 cluster. This cluster is a polycistronic miRNA gene, encoding six 
miRNAs like miR-17, miR-18a, miR- 92 ,miR-19a, miR-20a and miR 19b (the last three 
detected in our samples) (Mendell, 2008). 
miR-17-92 cluster is reported to be involved in the pathogenesis of human cancers 
suggested by amplification and overexpression in difuse B cell lymphomas and lung 
cancer (Ventura et al, 2008). This cluster increases the levels of proapoptotic protein 
Bim, inhibiting B cell development (Doeble et al, 2010). It has also been reported that 
hearts miR-17-92 deficient mice present ventricular septal defect, indicating the 
involvement of this cluster in heart development (Ventura et al, 2008). The present 
involvement of this cluster in several processes of interest of this study may indicate 
that the detected miRs can be involved in the regulation of heart development and 
would act as therapeutic agents in the future. 
In order to obtain important information about the cellular processes and interaction 
networks which key genes for cell diferentiantion/stem cell function are involved in, 
particularly in correlation with the expression profiles of their microRNAs regulators, it 
was important to characterize the gene expression profile of each population. This kind 
of information can allow us to understand the origin and fate of the cell populations 
under study and how their phenotype is finedtuned by these small molecules and the 
regulatory networks they establish. As referred the available material was very limited, 
so more focused qPCR based procedures were adopted in order to quantify the 
expression of genes that are already known to be important markers of relevant 
biological processes like stem cell maintenance and cardiac cell differentiation.  
We were able to set up the conditions required to perform a focused qPCR expression 
profiling of key genes involved in cardiac cell differentiation, but unfortunately we were 
unable to obtain samples with quantifiable amounts of RNA.  Even though, we decide 
to perform preliminary assays on the available samples by qualitative RT-PCR of 
several of our target genes, using the endogenous GAPDH mRNA as housekeeping 
control.  
The results obtained show a consistent improvement in the quality of RNA samples 
isolated from heart Sca1 positive stem cells. We also performed a quantification assay 
for Pitx2 and GAPDH and the results obtained suggest that heart Sca1 positive stem 
cells express the Pitx2 mRNA at a level that is closer to the one observed in the 
embryonic heart than to bone marrow stem cells. In the future, we will be able to 
improve the quality of the obtained RNA and establish a gene expression profiles for 
the three cell populations, connecting them to their respective microRNA profiles. 
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For future work, it would be important to validate the expression data obtained from 
isolated cell samples in a more preserved tissue context. A possible approach is the 
analysis of microRNA expression by in situ hybridization. The detection of microRNAs 
by this technique is slightly complicated since the levels of expression are often very 
low and due to the small size of the molecules. The most sensitive techniques make 
use of the locked nucleic acid (LNA) chemistry. LNAs are nucleotide analogs that 
improve hybridization properties of DNA oligonucleotides, constituting a sensitive 
method for miRNA detection (Obernosterer et al, 2007 and Silahtaroglu et al, 2007). 
After the validation of the results, functional assays for characterize the role of 
identified microRNAs can be perfomed. Modulation of miR regulated gene expression 
networks by small oligonucleotide mimics or antagonists – “antagomirs” holds the 
potential of cell fate modification in vivo. These oligonucleotides can reduce levels of 
pathogenic or aberrantly expressed miRNAs and are currently the most adequated 
tools for miRNA inhibition. (Soifer et al, 2007) So, since the different microRNA 
expression levels characterize many diseases, the modulation of gene expression is 
likely to become an important therapeutic approach. These assays constitute an 
excellent opportunity to unveil a little more about the many processes that are fined 
tuned by microRNAs. 
Together these methods constitute promising validation approaches and functional 
assays to perform in the future, after identifying the candidates that may act as key 
regulators of the processes of cell proliferation and differentiation. 
In this work, we were able to obtain new perspectives into the selected cell populations. 
So as the microRNA regulation as attracted attention and revealed increasingly 
importance in development and disease, we hope that by identifying potential 
regulators of stemness and differentiation of the stem cell population present in the 
adult heart we could take another significant step into the better understanding of this 
subject. 
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7. Appendix 
Table S1: List of genes/tissues/primer sequences used for gene expression profiling 
Gene Tissue PrimerSequence 
Irx3 Iroquois related homeobox 3 –Drosophila 
Heart/Eye/Mammary 
gland/Muscle (Adult) 
Fw_AGCCGGAGAGTGGAACAGAT 
Rev_TGGTTGAAAAGTTAAGACGAGGA 
Irx4 Iroquois related homeobox 4-Drosophila Fetal heart 
Fw_TCTGAACAGCTTCGAGTCCA 
Rev_CCTTCAGTGTGCTGGTGGT 
Irx5 
Iroquois related homeobox 5 – 
Drosophila 
Lung/Eye/Salivary gland 
(Neonatal) 
Fw_GAATCAGGAGGAGCAGAGCA 
Rev_CTTCGGAGGACGACTCCTT 
Bmp2 Bone morphogenetic protein 2 Thyroid/Uterus/Bladder 
Fw_GACTGCGGTCTCCTAAAGGTC 
Rev_GACAAGGGTCGGCTGGAT 
Bmp4 Bone morphogenetic protein 4 Pancreas 
Fw_TTCTGCAGGAACCAATGGAG 
Rev_GCATTCGGTTACCAGGAATC 
Tbx2 T-box 2 Adrenal gland/Blood (Neonatal) 
Fw_TGACAAGCATGGCTTTACCA 
Rev_GTAGGCAGTGACAGCGATGA 
Tbx5 T-box 5 Heart/ Bladder/Eye (Neonatal) 
Fw_GGATGTCTCGGATGCAAAGT 
Rev_TAGGTGGGGGCAGAAGGT 
Ankrd1 Ankyrin repeat domain 1 
Cardiac 
muscle/Pancreas/Salivary gland 
Fw_CCGACGTCTGCGATGAGTAT 
Rev_TGGCTGTGGATTCAAGCATA 
Gja1 
Gap junction membrane channel 
protein,alpha1 
Connective tissue/Heart 
Fw_GAAAGAGAGGTGCCCAGACA 
Rev_ATCACCCCAAGCTGACTCAA 
Gja5 
Gap junction membrane channel protein 
alpha5 
Embryonic tissue/Heart/Uterus 
(Fetal) 
Fw_GGAGGAAAGGAAGCAGAAGG 
Rev_ATGCGGAAAATGAACAGGAC 
Mef2C Myocyte enhancer factor 2C 
Brain/Heart/Inner 
hear/Muscle/Tongue (Fetal) 
Fw_CAGACATTGTGGAGGCATTG 
Rev_TGGGATGGTAACTGGCATCT 
Cited 1 
Cbp/p300-interacting transactivator with 
Glu-Asp rich carboxy-terminal domain 1 
Extraembryonic 
Tissue/Heart/Skin/Uterus 
Fw_CTTCGCGGAGACCAACAG 
Rev_CTGGTTGGCATCCTCCTTC 
Hesx1 Homeobox gene expressed in ES cells Embryonic tissue 
Fw_GTTGGTACCGAGGACGAAGG 
Rev_CCAAATCTGGATTCTGTCTTCC 
Actc1 Actin alpha, cardiac muscle 1 
Cardiac muscle/Embryonic tissue 
(Fetal) 
Fw_TTTGTCACCACTGCTGAACG 
Rev_GAGTCTCTGGACAGCGGAAG 
Nkx2.5 
Transcription factor related locus 5 – 
Drosophila 
Heart/Pancreas (Neonatal) Fw_CTGACCCAGCCAAAGACC 
Rev_CGCTCCAGCTCGTAGACC 
T Brachyury Ovarius/Embryonic tissue 
Fw_CTCCAACCTATGCGGACAAT 
Rev_TGGTACCATTGCTCACAGACC 
Tnni3 Troponin I, cardiac 3 Heart/Stomach 
Fw_CTTCAGGACTTATGCCGACAG 
Rev_GCATCTGCAGAGATCCTCACT 
Myl1 Myosin light polypeptide 1 
Tongue/Prostate/Embryonic 
tissue/Adipose tissue/Heart 
Fw_GGGAGAGAAGATGAAGGAGGA 
Rev_ATTGCGTGCTTGAAAACTCC 
Myl2 Myosin light polypeptide 2 Cardiac Muscle 
Fw_CTGCCCTAGGACGAGTGAAC 
Rev_TCAGCCTTCAGTGACCCTTT 
Shh Sonic hedgehog Adrenal gland/Bladder 
Fw_AGACCGGCTGATGACTCAGA 
Rev_CCACTGCTCGACCCTCATAG 
Gata-4 Gata binding protein 4 
Heart/Intestine/Pancreas/Testis 
(Fetal) 
Fw_CCCCAATCTCGATATGTTTGA 
Rev_TTGATGCCGTTCATCTTGTG 
Fgf8 Fibroblast growth factor 8 Embryonic Tissue 
Fw_CACACAGCGACATGTGAGG 
Rev_GAAGGGGTCTCCGTCTTCTG 
Pitx2 
Paired like homeodomain transcription 
factor2 
Bladder/Glands/Tongue/smooth 
muscle 
Fw_AGTCCGGGTTTGGTTCAAG 
Rev_GTACGAATAGCCGGGGTACA 
Hand2 
Heart and neural crest derivatives 
expressed transcript 2 
Heart/Adrenal 
Gland/Extraembryonic 
tissue/Uterus (Adult) 
Fw_GCTGAATGAGATCTTGAAAAGC 
Rev_TGCAAGAAGTCCTCAGAACG 
Isl1 Transcription factor,LIM/homeodomain 
Heart/Adrenal 
gland/Pancreas/Spinal cord 
Fw_TATCCAGGGGATGACAGGAA 
Rev_TTGACCAGTTGCTGAAAAGC 
GAPDH 
Glyceraldehyde 3-phosphate 
dehydrogenase 
High expression in most of the 
tissues – housekeeping genes 
Fw_  TGCACCACCAACTGCTTAGC  
Rev_ GGCATGGACTGTGGTCATGAG 
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Table S2: Data from qRT-PCR plate assays for each sample  
 Bone Marrow Embryo  Heart stem cells 
MicroRNAs BM 
1a' 
BM 
1b 
BM 
1 
BM 
2 
Emb  
1 ng 
Emb 
1 
Emb  
2 
Emb  
3 
Sca 
1.1. 
Sca 
1.2. 
Sca  
1.3. 
miR-18ª 32,36 36,74 31,52 31,34 32,92 29,35 26,99 27,29 0,00 0,00 0,00 
miR-19ª 30,38 33,37 29,95 30,90 31,51 28,21 24,97 25,68 0,00 38,16 0,00 
miR-19b 29,92 0,00 29,57 31,18 31,75 28,05 25,01 25,42 39,72 0,00 38,25 
miR-24 31,30 34,10 31,11 30,97 34,30 30,92 28,61 29,14 0,00 37,97 33,13 
miR-25 28,57 31,62 28,27 29,12 32,85 29,44 27,01 27,55 37,22 35,68 34,60 
miR-17-5p 31,68 34,53 31,12 31,80 33,55 29,58 26,89 27,36 0,00 0,00 0,00 
miR-30c 30,61 32,66 30,21 28,34 32,20 28,36 26,36 26,29 0,00 37,27 32,59 
miR-34ª 34,12 37,48 34,00 31,28 37,09 33,76 29,20 31,45 0,00 0,00 0,00 
miR-106ª 30,45 33,50 29,90 28,08 32,40 28,55 26,01 26,39 0,00 0,00 0,00 
miR-106b 32,23 33,49 31,92 29,44 33,73 31,06 28,02 28,26 0,00 0,00 0,00 
miR-130b 34,52 0,00 35,16 34,84 37,18 34,02 31,11 31,39 0,00 0,00 0,00 
miR-141 0,00 0,00 39,86 0,00 37,38 38,02 35,49 35,72 0,00 0,00 0,00 
miR-150 31,60 33,86 31,50 31,89 34,04 30,30 27,29 28,05 37,86 39,75 33,26 
miR-199ª 38,59 0,00 37,18 37,16 36,10 33,70 30,84 31,29 0,00 0,00 0,00 
miR-200b 33,38 36,40 33,29 34,17 36,65 33,30 31,42 32,07 0,00 0,00 0,00 
miR-200c 36,76 0,00 35,57 38,42 36,40 33,41 31,51 33,27 0,00 0,00 0,00 
miR-301 34,35 38,14 34,34 0,00 33,46 31,09 27,29 27,77 0,00 0,00 0,00 
miR-302ª 38,90 0,00 37,16 0,00 0,00 36,90 35,24 34,34 0,00 0,00 0,00 
miR-302b 37,44 38,34 0,00 35,74 0,00 36,86 35,28 37,78 0,00 0,00 39,23 
miR-302c 33,14 33,81 32,38 31,09 36,56 33,20 31,43 32,88 0,00 0,00 38,01 
miR-302d 36,87 38,89 36,12 34,83 34,42 31,60 29,01 29,37 38,82 38,44 39,87 
miR-367 34,76 36,61 35,98 34,65 36,06 34,61 32,30 32,27 35,62 36,60 35,81 
miR-368 0,00 0,00 0,00 0,00 0,00 0,00 39,60 39,10 0,00 0,00 0,00 
miR-369-
5p 
0,00 0,00 
0,00 0,00 
35,84 
33,34 32,10 31,38 
0,00 0,00 
0,00 
miR-369-
3p 
0,00 0,00 
0,00 0,00 
0,00 
0,00 0,00 0,00 
0,00 0,00 
0,00 
miR-370 21,69 23,36 21,26 22,63 24,24 21,05 19,05 20,38 34,85 31,74 28,37 
miR-371 36,37 0,00 35,37 36,22 36,38 33,11 31,92 32,97 38,29 0,00 0,00 
miR-372 33,13 35,47 32,94 33,11 35,21 31,83 29,53 30,99 0,00 0,00 38,56 
miR-373 32,94 35,02 32,89 0,00 35,51 32,06 31,11 31,39 36,66 0,00 35,32 
let-7ª 30,43 31,87 30,74 31,49 36,88 34,07 32,36 33,01 0,00 37,87 34,61 
let-7b  29,47 30,49 29,20 27,78 35,58 31,32 30,96 32,68 38,11 34,94 31,26 
miR-10a  31,15 33,69 31,01 29,24 36,29 31,66 31,73 32,30 0,00 37,40 34,88 
miR-10b 31,61 34,09 31,24 30,08 36,46 31,32 31,08 32,22 0,00 0,00 35,14 
miR-16 29,62 32,82 29,31 27,24 31,86 28,66 26,47 26,93 37,43 37,19 34,26 
miR-17-3p  34,44 35,60 31,60 31,92 33,12 0,00 30,84 32,04 0,00 0,00 37,39 
miR-20ª 29,42 32,10 28,59 27,26 31,18 0,00 25,53 25,91 0,00 0,00 0,00 
miR-20b 30,03 33,20 29,50 29,95 32,10 28,73 25,90 26,30 0,00 0,00 37,80 
miR-23a  28,74 31,10 28,30 29,26 33,07 28,76 27,37 28,09 34,65 35,43 31,15 
miR-23b  28,55 31,65 28,21 29,51 32,37 29,07 27,37 28,18 36,41 0,00 31,51 
miR-26a  30,36 32,98 30,05 30,47 33,72 30,59 28,42 28,90 39,24 36,19 32,27 
miR-26b  0,00 0,00 37,64 39,04 39,34 0,00 37,26 0,00 0,00 0,00 0,00 
 
Figure S1: Stem cell microRNA Array Arrangement 
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miR-30b  30,58 33,00 30,51 31,57 32,38 28,86 26,20 26,89 39,64 37,19 33,21 
miR-30d  30,91 33,76 30,53 28,36 32,77 29,84 27,20 27,21 0,00 38,96 33,52 
miR-32 38,17 0,00 0,00 36,83 0,00 39,10 35,33 36,04 0,00 0,00 0,00 
miR-33 36,30 39,00 38,15 36,40 0,00 37,25 34,51 33,77 0,00 0,00 0,00 
miR-92  27,96 30,77 27,85 26,10 31,88 28,49 26,41 27,14 38,28 39,02 35,28 
miR-93 30,34 33,80 30,30 28,00 33,26 29,99 27,24 27,65 37,51 0,00 37,39 
miR-99ª 33,43 35,77 33,24 31,09 34,67 31,78 29,83 29,76 0,00 0,00 36,82 
miR-101  0,00 0,00 39,57 38,49 38,42 39,19 35,02 36,60 0,00 0,00 0,00 
miR-107  33,70 34,54 32,93 35,17 34,66 31,46 28,47 29,21 0,00 0,00 0,00 
miR-126 31,55 34,74 31,07 32,14 32,03 28,44 26,79 27,27 34,56 34,59 29,78 
miR-130a  35,63 36,35 34,13 37,65 35,40 33,38 30,02 30,42 0,00 0,00 0,00 
miR-142-
5p 
36,15 0,00 
38,44 0,00 
38,33 
38,21 36,03 35,63 
0,00 0,00 
38,30 
miR-142-
3p 
30,49 34,03 
30,56 30,83 
35,50 
32,70 30,72 30,89 
0,00 0,00 
39,23 
miR-146ª 35,11 39,97 35,48 33,09 0,00 35,57 33,66 36,81 0,00 0,00 37,11 
miR-146b 31,81 35,52 31,27 30,06 34,37 32,38 31,75 33,20 35,82 34,80 37,13 
miR-155  35,28 38,57 36,65 34,38 0,00 37,39 37,46 36,32 0,00 0,00 0,00 
miR-181a  29,13 28,67 28,63 27,84 28,70 28,83 28,91 28,50 28,09 28,45 28,57 
miR-181b 30,98 33,57 30,62 29,45 34,03 31,32 29,92 29,70 37,24 37,58 33,74 
miR-181c 22,91 24,14 23,73 22,03 23,74 23,94 24,49 23,20 23,10 23,52 23,26 
miR-181d 33,40 34,89 33,25 32,95 37,18 33,95 30,26 31,05 0,00 0,00 34,70 
miR-191  29,41 31,58 29,08 29,55 33,66 30,59 28,50 29,00 0,00 37,61 35,98 
miR-193ª 33,94 33,80 32,70 33,55 36,86 33,12 31,06 32,13 0,00 0,00 36,54 
miR-193b 0,00 38,09 0,00 38,69 0,00 0,00 34,84 36,62 37,26 35,72 0,00 
miR-197  33,09 33,62 32,85 34,32 35,41 32,70 31,01 32,28 0,00 36,58 36,68 
miR-221  31,41 32,78 31,32 32,97 35,01 33,02 31,26 31,18 0,00 0,00 35,91 
miR-223  27,38 30,96 27,10 25,44 37,35 32,95 31,29 32,77 0,00 0,00 37,25 
miR-339 33,96 34,84 33,59 32,45 35,35 32,20 31,11 31,04 39,03 0,00 0,00 
miR-9 0,00 0,00 0,00 38,44 0,00 39,36 37,25 37,30 0,00 0,00 0,00 
miR-103 33,28 34,99 32,94 31,66 34,29 30,84 28,33 28,46 39,04 37,44 0,00 
miR-124ª 35,55 37,52 35,17 34,97 38,77 34,03 32,95 34,12 37,98 0,00 38,78 
miR-125ª 32,00 33,67 31,68 30,18 32,77 29,97 0,00 28,36 34,49 34,52 32,14 
miR-125b 32,25 31,45 31,75 31,98 32,46 30,29 28,05 28,62 34,86 35,12 30,07 
miR-127 34,38 33,84 32,95 34,40 33,43 29,98 27,68 28,22 36,02 0,00 35,32 
miR-128ª 37,74 37,10 35,85 37,00 38,29 36,01 34,11 34,55 0,00 0,00 36,73 
miR-128b 37,04 0,00 35,52 38,99 37,13 34,83 32,90 34,00 0,00 0,00 0,00 
miR-132 30,98 31,00 31,26 31,51 31,28 31,16 31,12 31,03 30,89 31,87 31,20 
miR-134 37,17 36,96 36,15 39,75 35,96 32,10 30,58 30,78 0,00 0,00 0,00 
miR-135ª 28,55 29,87 28,44 27,70 30,76 30,39 30,36 30,30 29,74 30,18 29,59 
miR-135b 33,21 32,28 32,70 30,52 32,68 32,11 32,84 32,09 31,66 31,71 31,39 
miR-136 37,36 0,00 37,38 35,40 39,44 36,16 33,73 35,17 0,00 0,00 0,00 
miR-138 39,28 0,00 0,00 35,96 38,36 35,30 32,31 33,69 0,00 0,00 39,19 
miR-149 34,65 38,95 34,61 33,39 36,49 33,50 31,06 31,39 0,00 0,00 36,13 
miR-153 21,33 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 
miR-154 36,11 35,85 34,84 37,24 33,99 30,96 28,55 28,64 39,74 0,00 37,13 
miR-183 35,96 35,86 34,42 36,10 33,99 32,12 29,40 30,42 0,00 39,49 35,98 
miR-218 36,90 39,23 36,94 38,26 34,77 31,73 29,49 30,13 37,12 37,09 37,31 
miR-219 36,32 38,78 35,26 38,64 38,69 35,36 32,01 31,88 39,34 38,48 38,67 
miR-222 33,19 33,69 31,59 32,91 36,35 34,24 32,22 33,99 0,00 0,00 38,68 
miR-1 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 
miR-122ª 34,46 39,34 34,49 34,26 33,07 30,62 26,73 27,49 37,39 38,74 34,85 
miR-133ª 35,74 36,26 34,62 34,13 32,04 28,30 25,55 25,80 37,18 37,11 32,00 
miR-133b 37,82 0,00 36,42 34,93 33,09 29,55 26,63 26,71 38,21 38,73 33,55 
miR-195 31,65 34,40 31,39 29,93 33,77 30,59 28,56 0,00 0,00 0,00 33,90 
miR-206 35,18 37,51 34,43 33,74 38,71 34,90 32,87 33,28 33,98 0,00 39,56 
U6 35,46 35,79 34,39 34,09 36,20 33,62 32,65 32,47 0,00 0,00 33,72 
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Table S3: Identification of potentially unreliable primers in the qPCR miR Stem Cell 
Array. Outlier Ct and ΔCt values identified in the 10ng-1ng sample comparison are 
presented. 
 
Table S4: List of targets and processes – GoElite (version 1.2.) 
MicroRNA 
Process Targets 
miR-23 a 
cell division site Myh2|Nf2|Tpm3 
DNA damage checkpoint Foxo4|H2afx|Xpc 
 negative regulation of cell 
adhesion 
Atp5b|Cml1|Myo1f 
miR-23b 
DNA damage checkpoint Foxo4|H2afx|Xpc 
 
Calmudolin binding Camk2a|Gap43|Iqcb1|Kcnn2|Marcksl1|Myh1|Myh4|Myo1f|Slc8a1|Strn3 
 
miR-125 a 
cell surface Cd200r2|Cd200r4|Cd59b|Chrna4|Cr2|Emr1|Enpep|Fcgr1|H2-D1|H2-
Q1|Igsf5|Mrc1|Spam1|Tm7sf4|Tnf|Treml1 
cell recognition Adam1a|Crtam|Fcgr1|Jmjd6|Zp3r 
miR-125b 
positive regulation of 
transcription factor activity 
Abra|Nfam1|Tnf 
blood vessel development Anpep|Bai1|Cdx2|Eng|Enpep|Gata2|Gja7|Itga7|Itgav|Jmjd6|Pgf|Plg|Sp
hk1|Tgfb2|Tnfrsf12a|Vegfb 
miR-126 
regulation of gene expression Cdkn2a|Csf2|Ireb2|Irx5|Myb 
stem cell differentiation Dicer1|Rif1|Tcf3 
response to DNA damage 
stimulus 
Alkbh2|Atm|Cdkn2a|Cib1|Dclre1a|Eme1|Gtf2h2|Mcts1|Neil3|Pnkp|Poli|
Rev3l|Rif1|Setx|Xrn2 
G1/S transition of mitotic cell 
cycle 
E2f5|Myb|Rps6 
organ growth Cdkn2a|D230044M03Rik|Ddr1|Dlg1|Drd3|Enox2|Gap43|Gpam|Lgmn|M
cts1|Pou3f2|Sertad1 
cell cycle checkpoint Atm|Mad2l1bp|Rps6 
embryonic organ Gli1|Neurod1|Sp3 
MicroRNA 10 ng – Ct values 1ng – Ct values Average 
miR-141 38.02 37,38 -0,64 
miR-367 34,61 36,06 1,46 
let-7b 31,32 35,58 4,26 
miR-10a 31,66 36,29 4,63 
miR-101 39,19 38,42 -0,77 
miR-142-5p 38,21 38,33 0,12 
miR-181a 28,83 28,70 -0,14 
miR-181c 23,94 23,74 -0,20 
miR-132 31,16 31,28 0,12 
miR-135a 30,39 30,76 0,37 
miR-135b 32,11 32,68 0,57 
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morphogenesis 
unidimensional cell growth Cdkn2a|Ddr1|Enox2|Gap43|Mcts1|Sertad1 
Segmentation Atm|Mllt3|Ripply2|Tcf3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S5: miRNA targets from interaction networks for cell proliferation and 
differentiation 
Process 
Cell Differentiation (Figure 13) Cell Proliferation (Figure 14) 
VEGF-A miR-126 VEGF-A miR-126 
Bmpr1-b miR-125b Bmpr1-b miR-125b 
ERB-2 miR-125b/miR125a Notch1 percursor miR-23b 
Dicer miR-23a/miR23b RAR-alpha/RXR-alpha miR-23 a 
Cyp24a1 miR-125b p53 All top 5 miRs 
SMAD5 miR-23b SMAD5 miR-23b 
ESR1 miR-23a/miR-23b Notch1 miR-23b 
p53 All top 5 miRs   
Androgen Receptor miR-126/miR-125b   
RXR miR-23 a   
SMAD4 miR-23b   
RAR-alpha miR-23 a   
RAR-alpha/RXR-alpha miR-23 a   
 
 
Figure S2- Network of interaction from Enrichment Analysis for cell 
differentiation,miR-23b. 
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Fig S3- 
Previous 
electrophoretic 
analysis 
showing no 
expression of 
NKx2.5. (166 
bp), Hand 
(197), 
Mef2C(194 bp) 
in contrast with 
current assays. 
Ladder 50 bp 
(Mafalda 
Rasteiro and 
Sara Marinho) 
 
